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ABSTRACT
We use anisotropic optical tracers (also called magnetically modulated optical
nanoprobes – MagMOONs or MOONs for non-magnetic nanoprobes in this dissertation)
to study biophysical processes such as enzyme-catalyzed cleavage through tissue,
intracellular transport of these tracers and cytotoxicity based on this transport. The
anisotropic optical properties cause these tracers to blink when rotating. This blinking is
distinguishable from the background and can be tracked on a single-particle level in the
absence of tissue, or for an ensemble average of tracers blinking through tissue. An
alginate gel containing these tracers in the form of a thin film can be used as a sensor to
detect alginate lyase, a protease of alginate gel. As the protease cleaves the gel, the
tracers are released, free to rotate and give a blinking signal that can be tracked under the
microscope. The tracers started blinking approximately 10 minutes after 2 mg/mL
alginate lyase addition, and this blinking was clearly detected through up to 4 mm of
chicken breast. Similar tracer-integrated gel films may potentially be employed to detect
bacterial biofilm formation on medical implants by sensing specific proteases that either
activate a related function or regulate biofilm formation. It can also be applied to other
biosensors and drug delivery systems based on enzyme-catalyzed breakdown of gel
components.
For intracellular transport and cytotoxicity, we apply the advantages of rotational
and translational single particle tracking in cytotoxicity studies by observing the tracers’
behavior with and without the presence of toxic substances. Both cyanide and 2-deoxyD-glucose or azide and 2-deoxy-D-glucose combinations immediately inhibited
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intracellular motion in J774A.1 macrophages upon addition. This result suggested our
method can potentially be applied to study cytotoxicity of particulate matter. More
importantly, tracking simultaneously the tracers’ translation and rotation reveals
interesting information about macrophage intracellular transport; for instance, tracers do
not rotate when sliding along microtubules. The data analysis also confirmed that sliding
periods contributed to a major portion of total movement but comprised a very small
portion of total observation time.

iii

DEDICATION
This work is dedicated to my parents, Mr. Nguyễn Văn Thịnh and Mrs. Lê Thị
Đon, who have always supported me and been my source of energy, and my brother
Nguyễn Tuấn Anh who first introduced me to the world of Science and Chemistry.

iv

ACKNOWLEDGMENTS
I would like to specially thank my advisor-mentor, Dr. Jeffrey Anker, for his
continuing guidance and support throughout my time doing research work at Clemson
University. I also thank Dr. Julia Brumaghim, Dr. Kenneth Christensen and Dr. Jason
McNeill for being in my committee. I have learned from them the scientific way of
thinking, reasoning, and problem solving. I thank the Chemistry Department and the
Vietnam Education Foundation for the fellowship that brought me to the U.S from
Vietnam. Last but not least, I thank my friends in the Anker’s group, especially Dr.
Fenglin Wang, Melissa Rolgaski, Donald Benza, Dr. Fathima Ameer, Gretchen Schober,
Unaiza Uzair, Dr. Hongyu Chen, and all the people I met at Clemson, specially Nhu-Y
Phan-Thien, Yamin Htet, Mioko Tamura, Liem Nguyen, Thanh To, and Maria Mullet,
who have shared with me the graduate school life.
This research work was supported by the NIH NIBIB grant award number
1R15EB014560-01A1; the South Carolina Research Authority NSF grant 2002593TO#0056 for the magnetic field control; the Spherotech Inc. for the magnetic
fluorescent particles, and the Vietnam Education Foundation for a fellowship to Khanh
Van Thi Nguyen.

v

TABLE OF CONTENTS
Page
TITLE PAGE .................................................................................................................... i
ABSTRACT..................................................................................................................... ii
DEDICATION ................................................................................................................ iv
ACKNOWLEDGMENTS ............................................................................................... v
LIST OF TABLES ........................................................................................................viii
LIST OF FIGURES ........................................................................................................ ix
CHAPTER
I.

INTRODUCTION ......................................................................................... 1
Lung Particle Toxicity ............................................................................. 2
Live/Dead Assays and Cytomagnetometry Approach
to Study Cytotoxicity ......................................................................... 4
Single Particle Tracking, SPORT, and our Approach
to Study Cytotoxicity with Anisotropic Optical Tracer Tracking ..... 9

II.

TRACKING MAGMOONS
TO DETECT GELATION AND DE-GELATION ............................... 16
Introduction ............................................................................................ 16
Method and Experimental Setup ............................................................ 22
Results and Discussion .......................................................................... 29
Conclusions and Future Work ............................................................... 44

III.

TRACKING ANISOTROPIC OPTICAL TRACERS (MOONS)
TO STUDY INTRACELLULAR TRANSPORT
AND CYTOTOXICITY ........................................................................ 45
Introduction ............................................................................................ 45
Method and Experimental Setup ............................................................ 52
Results and Discussion .......................................................................... 55
Conclusions and Future Work ............................................................... 68

vi

Table of Contents (Continued)
Page
IV.

SUMMARY AND FUTURE WORK ......................................................... 69

APPENDICES ............................................................................................................... 71
A:
B:
C:
D:
E:
F:

Poster: Using magnetic particle tracking
to study rotational transport in macrophages ......................................... 72
Poster: Magnetically modulated single particle tracking as a tool
to study cytotoxicity of airborne nanoparticles ...................................... 73
Matlab Script for Particle Tracking ............................................................. 74
Matlab Script for MSD Calculation ............................................................. 76
Matlab Script for Motion Classification ...................................................... 78
License Agreement ...................................................................................... 80

REFERENCES .............................................................................................................. 81

vii

LIST OF TABLES
Table
3.1
3.2

Page
Motion characterization: D, v and α ............................................................ 66
Motion characterization: Percentage of confined, diffusive
and directed motion................................................................................ 68

viii

LIST OF FIGURES
Figure

Page

2.1

Experimental setup....................................................................................... 27

2.2

Summary of gelation and de-gelation experiments ..................................... 29

2.3

Tracking individual MagMOONs to detect alginate
de-gelation by ammonium replacement ................................................. 32
Tracking individual MagMOONs to detect alginate
de-gelation by alginate lyase .................................................................. 34
Fluorescent imaging through turbid chicken breast tissue ........................... 37
Monitoring of MagMOON modulation through tissue
after adding denatured and active lyase to the alginate gel ................... 39
Detection through tissue the de-gelation by alginate ................................... 42
Fourier transform analysis to detect blinking
through different tissue thickness .......................................................... 43
Superimposed image of macrophages in transmitted light
bright field (gray) and fluorescence from MOONs (red)....................... 56
Position and intensity change of a single MOON particle with time .......... 58
Correlation between velocity and intensity change
of MOONs in cells (a), in glycerol (b), and by simulation (c).............. 60
Trajectories of MOONs in macrophages with
(NaN3 + 2-deoxy-D-glucose) addition (a) and no toxin addition (b) .... 62
MSD curves of simulated Brownian motion (a), motion in cell
with no toxin addition (b) and motion in cells with toxin addition (c) .. 65
Motion characterizations based on α ........................................................... 67

2.4
2.5
2.6
2.7
2.8
3.1
3.2
3.3
3.4
3.5
3.6

ix

CHAPTER ONE
INTRODUCTION
This dissertation describes some applications of anisotropic optical tracers to
study different biophysical processes such as the enzyme-catalytic cleavage under tissue
(Chapter Two), the intracellular transport and the cytotoxicity based on that transport
observation (Chapter Three).
In the introduction chapter (Chapter One), the potential toxicity of lung particulate
matters and its study need, and some proposed mechanisms for the toxicity of these
particles will firstly be presented. Different approaches to study cytotoxicity including
conventional live/dead assays and the in vivo cytomagnetometry methods developed by
Möller, Nemoto and others will then be summarized. Lastly, our novel approach of using
anisotropic optical tracers together with the single particle tracking technique to study
cytotoxicity will be introduced.
Chapter Two demonstrates in principle the through-tissue detection of enzyme or
protease activity by tracking single anisotropic optical tracers, to study chemically
induced viscosity change processes. This technique can be employed to detect bacterial
biofilm formation on medical implants or other biosensors and drug delivery systems
based on enzyme-catalyzed breakdown of gel components.
Chapter Three describes the application of anisotropic optical tracer tracking in
intracellular transport study as an approach to investigate cytotoxicity, and Chapter Four
summarizes these results and suggests future work.
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Lung Particle Toxicity

The rapid development of nanomaterials in industry and medicine has caused
growing concerns about potential nanomaterial hazards to human health and the
environment. Nanoparticles are particularly worrisome because their small size and large
surface area alter their biodistribution and bioreactivity. Nanomaterials can infiltrate to
the body via skin, respiratory tract, gastrointestinal tract, or direct injection (1). Airborne
nanoparticles such as asbestos fibers, smoke, combustion, and other ultrafine particulate
matter cause toxicity via pulmonary inflammation, oxidative stress, fibrosis, mutagenesis
and cancer (2-5).
According to the National Cancer Institute, in 2015 in the US, lung cancer, breast
cancer and prostate cancer have the 3 highest estimated numbers of new cases of all
cancers (> 220,000, 13.3% of all cancers), and the estimated deaths cases because of lung
cancer is the highest among all cancers (~ 160,000 cases, 26.8% of all cancers) (6).
Although about 90% of lung cancer cases are related to smoking, data collected by the
American Cancer Society from 1982 to 1998 over 500,000 adults from 51 districts
nationwide showed that each elevation of 10 µg of fine particulate air pollutant was
associated with ~ 8% increased risk of lung cancer mortality, whereas NO2, O3, CO
levels didn’t show such consistent association (7).
Despite the strong associations between particulate matter and lung diseases, the
biological mechanisms are still being elucidated (3, 5, 8-13). Lung particulate matter
toxicity depends on various factors including shape, size, solubility, surface area and
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chemical components, and the physicochemical interaction of the particle surface (10).
The toxicity mechanisms of these particles therefore are diverse and complicated.
Donaldson and colleagues proposed that carbon nanotubes with high aspect ratios such as
asbestos fibers can penetrate deeply due to their thin width, but they are not completely
enclosed by macrophages due to their length, leading to phagocytosis frustration and
failed clearance. The carbon nanotubes therefore will be accumulated in the lungs and
cause inflammation (9). Many studies suggested generation of reactive oxygen species
initiates toxicity, especially from metal or metal oxide nanoparticles (3, 10-13). For
instance, Schins and colleagues’ review on the inhaled particle toxicity to the lungs
suggested the particles themselves could directly generate reactive oxygen species (ROS)
or/and they can stimulate the ROS generation by target cells (primary) or by
inflammatory cells (secondary). The ROS in turn can cause DNA damage and
genotoxicity (3). Xing and colleagues also proposed three mechanisms of CuO and ZnO
nanoparticle toxicity: oxidative stress, coordination effects and non-homeostasis effects.
In the oxidative stress mechanism, the nanoparticles can generate ROS when they are in
contact with oxidative organelles like mitochondria or in acidic surrounding as in
lysosome. The excessively produced ROS disturbs the reactive oxygen production and
damages DNA. With the coordination effects, the dissolved Cu and Zn ions from
nanoparticles can bind to proteins, replace the important coordination atoms at the
binding sites of the proteins and cause major structural changes such as unfolding,
resulting in the inactivation of the protein function. Lastly, the appearance of extra metal
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ions from the oxide nanoparticles in excess of physiological tolerance is toxic because it
disrupts metal cation homeostasis in cells (10).
Although there have been several studies to elucidate the mechanisms and
evaluate toxicity, most of them are done in vitro, require high dose of toxins, and cannot
be observed in real time. In the next section a summary of some conventional assays for
toxicity evaluation will be presented, following by the in vivo cytomagnetometry
approach developed by Möller, Nemoto and others to study toxicity that can be carried on
in a live, dynamic environment and with low dose of toxins.

Live/Dead Assays and Cytomagnetometry Approach to Study Cytotoxicity

Cytotoxicity measurements are commonly based on live/dead assays (or viability
assays) such as the dye exclusion assays (trypan blue or propidium iodine staining),
lactase dehydrogenase (LDH) leakage, MTT, or ATP. In these assays, live and dead cells
are distinguished either by staining dead cells (trypan blue, propidium iodine) or by the
identification and measurement of a specific molecule, generated when cells are dead
(LDH) or alive (MTT, ATP assays).
More specifically, the principle of dye exclusion test is that live cell membrane is
intact so that dyes such as trypan blue or propidium iodide cannot enter the cytoplasm to
stain the intracellular compartments when cells are alive. However, these dyes can
penetrate through the non-intact dead cell membrane and stain the cell in blue with trypan
(14, 15) or bind to cell’s DNA, RNA emitting enhanced red fluorescence with propidium
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idodide (16). Similarly, in the LDH leakage assay, the amount of LDH outside of cells is
an indicator of cell dead because LDH is an intracellular enzyme that is released when
cells are damaged or injured, measured by its activity on a protease substrate forming dye
products that can be read by ELISA plate reader (17, 18). MTT or ATP, on the other
hand, is based on live cell activity. MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5diphenyltetrazolium

bromide)

or

MTS

(3-(4,5-Dimethyl-2-thiazolyl)-5-(3-

carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) are tetrazolium salts that are
reduced to formazan by dehydrogenase enzymes in mitochondria of live cells. After MTT
or MTS is added to the cell sample, the purple color of the formed formazan can be
quantified by a photospectrometer (19, 20). The ATP assay is based on the requirement
for ATP in oxidizing luciferin using luciferase to form oxyluciferin that emits
fluorescence. Measurement of fluorescence signal reflects ATP levels and hence the live
cell amount (21).
Cytotoxicity studies based on live/dead assays will not be effective if the toxic
agent is not concentrated enough to kill the cells. Although gene expression can be used
to identify early steps in apoptosis, such studies cannot be performed in situ. Meanwhile,
biophysical approaches can be used to dynamically study the toxicity in living cells or
even in vivo (in human or animal). The cytomagnetometry method is one excellent
example among biophysical approaches of which the development is briefly introduced
below.
In 1973 Cohen developed the magnetopneumography (MPG) method to detect
magnetic materials in human body that may enter stomach from food cans or lungs from
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welding. He first applied a strong external magnetic field to magnetize the unintentional
ingested/inhaled magnetic particles for a short time and then measure the RMF generated
by these particles in a shielded room. The measurable RMF suggested the MPG method
could be applied in toxicity study in two different aspects: detecting asbestos (toxic and
ferromagnetic) in the lungs of asbestos workers and determining lung condition with
Fe3O4 particles (non-toxic and ferromagnetic) as tracers (22). In 1979 Cohen continued to
use MPG to compare the clearance time of volunteer-inhaled Fe3O4 tracers from smoker
and non-smoker lungs. His results showed 50% of the dust retained in the lungs of
smokers after a year while in the non-smokers it was only 10%, indicating the smokers
had impaired clearance (23).
Following these directions, several researchers including Nemoto, Valberg,
Freedman and Möller have applied MPG to evaluate lung particulate matter toxicity both
in vitro and in vivo and at the same time characterize some important properties of
intracellular process. For instance, Freedman measured the ferromagnetic materials in the
lungs of different occupations such as welders, miners and asbestos workers (24).
Nemoto and Valberg estimated the viscosity and elasticity of the cytoplasm, and also the
randomization energy caused by macrophages using simple models (25, 26). One notable
conclusion from Nemoto study (25) was that the randomization of the particles’
alignment was due to intracellular process in macrophages, not likely caused by the free
diffusive Brownian rotation because the randomization energy was about 1000 times
greater than the free energy (kT) of Brownian motion. In 1993, Möller and Stahlhofen
also estimated the amount of dust in the lungs of dental technicians and welders and
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found levels of 22 and 500 mg, respectively, compared to only 0.3 mg in control subjects.
With the application of secondary magnetization, they determined the cellular energy,
intracellular viscosity and the half time clearance (110 days) (27).
In 1997, Möller used phagocytized micrometer-size ferromagnetic tracers as a
tool to non-invasively induce intracellular mechanical stress and observed the living-cell
response. After the first short pulse (30 ms) of high magnetic field (100 mT) application
and subsequent relaxation (2 – 5 min), a secondary magnetization was applied for about
10 s with a low magnetic field strength (0.2 – 3 mT) in the reverse direction to cause
particle twisting. The RMF again was measured from which intracellular mechanical
properties such as viscosity; elastic recoil and plasticity can be calculated. Their
observation that the viscosity increased when the mechanical stress increased is typical
for polymer solutions, indicating intact cytoskeletal networks in living cells. They
suggested the elasticity was mainly related to the dynamic rearrangement of
microfilaments. This study opened the door to investigate cellular dysfunction and drug
administration (non-invasive intracellular torque generation) (28).
The examples above are studies that evaluated the condition of lungs or, on a
more detailed scale, lung macrophages, using ferromagnetic tracers and the MPG
method. The same principle can be applied to study particulate matter toxicity if the
tracers themselves are the toxic particulate matter, such as asbestos. Even when the toxic
matters and the tracers are not the same, researchers can study toxicity by observing
tracers in the presence of toxins. In collaborative study by Möller and Nemoto, an
adapted MPG method was developed, called cytomagnetometry, to study in vitro and in
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real time the influence of cytoskeletal drugs on phagosome motion (29). This work was
followed by cytotoxicity studies of ultrafine (nanometer range) particles that cause
macrophage cytoskeletal dysfunction (30). In this cytomagnetometry method (29), the
basis and experimental conditions were the same as summarized above from (28), with
modifications for an in vitro instead of in vivo study. Cytochalasin D (CyD), colchicine
(CoL) and acrylamide (AcL), the cytoskeletal drugs of microfilaments, microtubules and
intermediate filaments respectively, were used to investigate their influence on
phagosome transport. The disintegration of intermediate filaments by AcL affected
neither stochastic nor directed phagosome movement. Microfilament disruption by CyD
caused a slowdown of the random motion (or the relaxation after magnetization) and a
small increase in cell stiffness. CoL depolymerization of microtubules reduced viscous
resistance and elasticity. The results implied that microfilaments were important in the
stochastic transport of phagosome whereas microtubules were essential for the static
mechanical properties of the cell (29).
In 2002, Möller and colleagues applied a cytomagnetometry method (called
magnetic twisting cytometry – MTC in subsequent studies) to evaluate the cytotoxicity of
ultrafine particles (UFP) including TiO2, elemental carbon, commercial carbon black,
diesel exhaust particulate matter, and urban dust. The results showed cytotoxicity effects,
such as impairing phagosome transport and increasing cell stiffness, of all UFP types at
concentrations from 100 ug per mL per 106 cells, except for TiO2; and the urban dust and
diesel exhaust particles were found to cause cytoskeletal dysfunctions as much as
elemental carbon (30). This research work is a representative example of using
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ferromagnetic tracers and cytomagnetometry technique to study the cytotoxicity of nanosize materials that we want to apply in our research work to study lung particle toxicity.
Although MTC is a useful method to study lung particle toxicity, it does not show
individual tracer behavior and therefore misses reporting the regional properties. We have
modified the cytotoxicity experimental methods using MTC to implement a single
particle tracking technique that will be introduced in the following section. In our
approach, ferromagnetic tracers are replaced by anisotropic optical tracers that have
orientation-dependent optical properties (these tracers can be magnetic or not, depending
on the experiment) and the magnetic sensing system of MTC is replaced by a light
microscope. Although our current method is in vitro with cultured macrophages only, the
in vivo study of human lungs could be achieved with an endoscope.

Single Particle Tracking, SPORT, and Our Approach to Study Cytotoxicity with
Anisotropic Optical Tracer Tracking

As previously mentioned, our approach to study cytotoxicity is the combination of
modified MTC to apply for optical system with single particle tracking technique but
before explaining in more detail the method single particle tracking (SPT) will first be
introduced.
SPT uses a microscope and integrated camera to record hundreds to thousands or
more images over time (time-lapse microscopy) of multiple individual micrometer- or
nanometer-size tracers (organic dyes, fluorescent dyes or proteins, or particles such as

9

quantum dots or gold nanoparticles) (31) in order to obtain dynamic information about
the tracers’ surroundings or the organelles the tracers are associated with. Tracers’
brighter signal (intensity) over the background of the image is the key point of the
algorithms to identify and extract their trajectories. Data analysis with the help of
computational tools to characterize the tracers’ movement reveals insights into the
properties or mechanisms of the studied system.
SPT is commonly used to study dynamic cell-related biophysical processes where
it is referred as live-cell SPT. Live-cell SPT of a population of tracers over different
regions in cells will provide not only the average properties of the whole population but
also the local information from each individual particle in that population. Information
such as forces that drive a particular particle motion and rate of movement can be
obtained (32). The main advantage of using SPT to study biophysical processes is that it
helps resolve different subpopulations in their dynamic states.
An early application of SPT was to identify kinesins’ role in the movement of
plastic beards along microtubules from squid axons in vitro (33, 34). Since then SPT has
been utilized to study various biophysical processes including but not limited to
extracellular, intracellular (in particularly intracellular transport) and cellular membrane
dynamics, as being described and reviewed in (35-39). For example, Selvin and Yildiz
used the Fluorescence Imaging with One Nanomter Accuracy (FIONA) technique to
characterize the movement of the three molecular motors myosin V, myosin VI and
kinesin with 1 nm accuracy. FIONA precisely determined the center of a fluorescent spot
by fitting the spot’s point spread function with a two-dimensional Gaussian function.
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Collecting more photons and reducing background also improved the precision. For
molecular motor movement study, both the head and the level arm of the motors were
labeled with an organic dye and the dyes were tracked during motion. Their results
showed that all the three type of molecular motors walked in a hand-over-hand manner
(35). Cappello and colleagues first used quantum dots (QDs) –much brighter tracers than
normal dyes – in intracellular tracking to characterize kinesin movement in live HeLa
cells. They tagged kinesin with a single QD, tracked and computed the mean square
displacement (MSD) in order to characterize motions. Of the 75 QDs (radius ~ 15 nm),
they identified approximately 13% had directed motion, and the remaining had random
motion with a diffusion coefficient of 0.031 +/- 0.002 µm2/s (36). The 18 nm super-bright
and photo-stable fluorescent probes formed by precipitation of highly fluorescent
conjugated polymers were also used, with extremely low concentration of hundreds pM
range, in cellular uptake mechanism study (40). Recent reviews indicate SPT is a
powerful technique in drug and gene delivery research that aids in unraveling cell entry
mechanisms of viruses and pharmaceutical nanoparticles (41-43).
Tracking requires accuracy to properly evaluate the investigated moving system.
The resolution of SPT depends on factors listed in the equation below:

s 2 a 2 / 12 8πs 4 B 2
〈 Δx 〉 =
+
+ 2 2 , (Equation 1)
N
N
a N
2

where
Δx is the error in the particle position
s is the standard deviation of the point spread function
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N is the number of photons detected
a is the pixel size
B is the background noise
This equation will be used to estimate the resolution of our tracking.
Although SPT is a powerful tool to study real time in live cells and provides
regional information from each individual tracer, translational tracking (tracking based
only on the displacement in X and Y coordinates) has difficulties in a moving system and
at low magnifications as in endoscopes. Meanwhile, rotational motion, if it can be
tracked, is not altered by small changes in the studied objects’ position.
There have been different approaches for rotational tracking as reviewed in (44).
The Selvin group developed a technique called defocused orientation and position
imaging (DOPI) by combining the FIONA to identify the position and defocusing the
object (QD rod) to determine its orientation, because defocused image has lobes and
fringes representing orientation that can be classified by comparing to respective
simulations. Using this technique, Selvin and colleagues were able to confirm the 37 nm
step size of myosin (45). Ning Fang and colleagues have used differential interference
contrast (DIC) microscopy to develop the DIC-based single particle orientation rotational
tracking (DIC-based SPORT) for rotational tracking of plasmonic nanorods. The key
points of this technique are an anisotropic optical tracer (nanorod) and the DIC
microscopy capable of identifying the tracer orientation based on its intensity. The basis
of DIC is summarized as following. A polarizer is used to polarize the illumination beam.
A first Normarski prism is then placed to split the polarized illumination beam into two
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beams that are orthogonal and shifted by a sub-wavelength shear distance, resulting in
two intermediate bright-field images that are later shifted back by a second Normarski
prism as well as being projected to the same polarization plane by a second polarizer.
This creates an interference image with bright and dark areas, corresponding to
constructive or destructive interference depending on the specimen thickness and/or
refractive index. This method was used to study intracellular transport by motor proteins
both on engineered surface and in live cells (46). Working well for rotational tracking but
the localization of a particle determined by conventional DIC has limitation because of
the disproportionate bright and dark parts. A later publication from the same group
described the implement of superlocalization with DIC for tracking both translation and
rotation. Herein, a dual-modality was applied where a dichroic mirror is placed after the
second prism and before the second polarizer of the DIC setup to create two channels,
one follows the path as in a normal DIC system as described above to give rotational
information and the other doesn’t have a polarizer, and produces a normal bright-field
image used for translational tracking. This method was applied to track endocytosed gold
nanorods in live cells with nanometer-scale localization precision (47). Applying the
same principles with the described dual-modality, this group showed the tracer’s position
in correlation with the microtubule it was on by combining DIC with fluorescence (48).
In a simpler system with fluorescence or dark-field light microscopy, rotational
and translational tracking can also be obtained by measuring the fluorescent or scattering
intensity of optically asymmetric particles when they rotate (49-51). In place of the
nanorods as in the Fang group experiments, tracers can be micro/nano-spheres, fabricated
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by vapor depositing a thin layer of metal (gold, silver, or aluminum) on to one
hemisphere so that the tracers will have orientation-dependent fluorescence or scattering.
This causes the change in intensity when tracers rotate as they move. The motion of these
anisotropic optical tracers in time is observed by a microscope and recorded by a camera.
If the tracers are magnetic, they could serve as multi-purpose probes to study intracellular
processes, to generate intracellular mechanical force, or to control local drugs delivery to
cells.
In our approach to study biophysical processes by tracking anisotropic optical
tracers in real time, we want to combine Möller approach to study cytotoxicity with the
advantages of SPT to add the benefits from the ensemble of multiple particles for both
local and global, both translation and rotation information. We fabricated anisotropic
optical tracers (MOONs or MagMOONs) from spherical probes by vapor deposition one
side of these probes with a think metal layer. This metal layer limited light penetration,
causing different optical property compared to the non-coated side. We take from
Möller’s studies the idea of using tracers to study toxicity, but we innovate the idea of
tracking these tracers individually. From the viewpoint of rotational and translational
tracking, the novelty is applying the technique to study toxicity. Our approach is expected
to detect toxicity effects at low doses that cause slight inflammation or cytoskeletal
impairment before the effect becomes so serious that it kills cells.
In summary, tracking rotation and translation of anisotropic optical tracers is
potentially a novel toxicity assay that optically measures intracellular transport and can
be done in situ. Single particle studies will reveal information about the mechanism of
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cytoskeletal impairment that is comparable to conventional techniques, especially the
magnetometry MTC method reported by Möller and others, and at the same time gaining
more detailed information of toxin effect on macrophage phagocytosis and transport. Our
approach will be a complementary tool to conventional cytotoxicity assays.
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CHAPTER TWO
TRACKING MAGMOONS TO DETECT GELATION AND DE-GELATION

Before going into the details of our intracellular transport and cytotoxicity study
in Chapter Three, this chapter will present the application of anisotropic optical tracers to
in situ detect through tissue the chemically induced de-gelation process of alginate gel.
This is a demonstration to show proof-of-principle for detection of bacterial biofilm
formation on medical implants by sensing specific proteases that either activate a related
function or regulate biofilm formation. It can also be applied to other biosensors and drug
delivery systems based on enzyme-catalyzed breakdown of gel components.

Introduction

Alginate gels and their derivatives are widely used for implanted devices and drug
delivery (52, 53). These gels can serve as a local source of proteins, nucleic acids, and
small molecule drugs; and gel degradation will release these molecules (54-58). The gels
are also used in wound dressings and as a platform for cell cultures (59, 60). They are
increasingly used in tissue regeneration by carrying and delivering proteins and cells that
promote bone, muscle, cartilage and blood vessel formation (61-64).
In general, a gel allows small molecules and particles to diffuse through it, but
effectively prevents the motion of particles that are large compared to the gel network
mesh size. The gel can be dissolved by either breaking the crosslinks in the gel network,
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or enzymatically cleaving the polymer backbones, allowing rapid drug release. After the
gel breaks down, larger probes become free to move, and the effective viscosity
dramatically decreases. Detecting this rapid change in viscosity during de-gelation can
also be used to determine the activity of enzymes that digest the gel. In vitro viscosity can
be measured using standard viscometers such as capillary (65), plate, or falling-ball
viscometers (66). To measure local viscosity in confined systems such as a cellular
cytoplasm or measurement through tissue, more sophisticated methods are needed to
move a probe and measure its response. Möller and colleagues measured the local
viscoelastic moduli of the macrophages cytoplasm by recording the deflection and
recovery of 1.3 µm magnetic beads when applying twisting force pulses (67). They also
studied the intracellular phagosome transport in macrophages by monitoring the RMF of
~ 106 phagocytized magnetic particles after initially magnetizing them with a strong
magnetic field. The RMF decayed as each particle rotated away from its initial
orientation by independent intracellular transport forces in each cell (29, 68). This is an
excellent non-invasive approach for intracellular investigation. However, they required ~
106 particles to measure the RMF and this approach cannot take advantage of SPT to
obtain local information of the surrounding of each individual particle using this method.
In addition to magnetometry approaches, mechanical methods based on
oscillation or vibration of a cantilever have also been developed (69-71). For example,
Ehrlich and co-workers designed a wireless biosensor device for early biofilm detection
based on changes in the resonance frequency of a cantilever in response to change in
viscosity as a polysaccharide gel was cleaved by its enzyme galactosidase (69). This
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galactosidase enzyme was designed to activate upon binding of RAP (ribonucleic acid
[RNA] III activating protein), a quorum-sensing molecule generated by bacteria. When
activated by RAP, the enzyme cleaved a polysaccharide substrate and produced glucose,
which broke down a dextran-Concanavalin A hydrogel by competing with the dextran for
binding to the concanavalin A crosslinks. This RAP-activated gel breakdown reduced the
hydrogel viscosity and was detected as an increase in the cantilever’s amplitude and
resonance frequency due to reduced viscous damping. This approach is sensitive but
requires a power source, relatively large and complex electronics, and antenna to drive
the cantilever circuit and transmit the signal wirelessly.
Inspired by Ehrlich’s work, we aimed to create a simple yet effective
fluorescence-based sensor to detect changes in viscosity due to de-gelation activity, and
monitor the fluorescence through tissue. In place of piezoelectrically driven cantilevers,
we applied an oscillating magnetic field to drive the rotation of MagMOONs embedded
in the gel, and measured the ability of the MagMOONs to rotate and align with the field
by detecting the modulated fluorescence signal. In general, the rotational motion of
magnetic particles depends upon the applied magnetic field, the magnetic moment of the
particle, shape and size-dependent drag, and the viscoelastic properties of the
environment. For a given set of particles, the rotational motion can be used to monitor
changes in the environment. If particles are optically asymmetric, the motion can be
tracked optically on a single particle level (provided that the particles can be resolved,
i.e., tissue does not scatter the light). For example, in 1950, Frances Crick monitored the
rotational motion of micron-sized aspherical particles in response to pulsed magnetic
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fields to measure the viscosity in chick fibroblasts (72). Optical tracking of rotating
magnetic particles was used to monitor changes in drag during growth of single bacteria
on MagMOONs (73) to monitor changes in shape of single cancer stem cells (74), to
measure the viscosity of butterfly saliva (75), and to detect bacteria based on changes in
viscosity when bacteria excrete biofilm polymers (76). In addition, particle rotation has
been used to track intracellular transport (46, 49). McNaughton and colleagues used
asynchronous magnetic bead rotation (AMBR)-based biosensor to measure viscosity and
to detect microbial growth based upon increased drag on the magnetic particles. They
applied a circularly rotating magnetic field that caused the particles to rotate at the
driving frequency (with a phase delay) when the rotation was slow (and/or the field is
strong), or in an asynchronous rocking motion superimposed with continuous rotation
when the rotation exceeded a critical frequency (ωc = mB/κƞV), where B is the applied
field, κ is a shape factor (6 for a sphere), ƞ is the viscosity, and V is the particle volume.
When the viscosity of the environment surrounding the bead changed or the effective
volume changed (e.g., due to a bacterium binding onto the bead surface), the rotational
period of the bead changed accordingly (76, 77). This method has high sensitivity at the
single-bacterium level (74). However, the method does not work unless single particles
can be resolved, since each particle rotates asynchronously and no large group of
particles would be aligned with each other at any given time.
Although local viscosities can be probed by optically tracking the motion of
magnetically driven particles in vitro, such tracking is challenging to perform through
tissue for three reasons: first, the excitation light and probe fluorescence is attenuated by
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the tissue; second, tissue autofluorescence can obscure the probe signal; third, tissue
scattering can cause the image to blur, preventing accurate determination of the position
of single particles. Fortunately, these limitations can be circumvented using
MagMOONs. MagMOONs are fluorescent particles with an orientation-dependent
fluorescence signal generated by vapor depositing metal onto one hemisphere of a
fluorescent particle, and a magnetic moment that causes them to align in an external
magnetic field, (see Fig. 2.1 and methods section). The MagMOONs feel a torque to
align with an external magnetic field. If the MagMOONs are free to rotate in an
oscillating external magnetic field, they blink as they flip between dim and bright
orientations. Tissue does indeed attenuate the MagMOON fluorescence signal, but
acceptable signals can be obtained by choosing the proper wavelength of the fluorescence
excitation and emission as well as adjusting particle concentration. In the current study, a
50 mW 514 nm Ar ion excitation laser was found to be sufficient to detect through 4 mm
tissue thickness 400 µL MagMOONs solution 1 to 2 x 104 particles/mL (ca. 50 to 100
ng/mL, formed ~ 800 µm thick layer of solution between two 1 inch diameter coverslips).
It is expected that larger depths will be attainable for higher concentrations of red or nearinfrared exciting and emitting MagMOONs. The problem of autofluorescence can be
overcome because only the probe signal is modulated by the external magnetic field. This
allows measurements even when the background fluorescence is thousands of times more
intense than the probes’ fluorescence and changes in time due to photobleaching and
physiological changes, as long as these changes occur at different frequencies from the
MagMOON modulation. Ultimately, the signal-to-noise ratio is limited by noise on the
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background at the driving frequency, including shot noise on the background
fluorescence (78). Importantly, tissue scattering blurs the probe signal with a pointspread-function approximately equal to the tissue depth (79, 80) and also reduces the
contrast between bright and dim MagMOON orientations as scattering scrambles the
direction of excitation and emission light (81) Although this scattering prevents single
particles from being resolved and tracked in tissue, we can still measure the intensity
change from an ensemble of particles that are driven to rotate and blink together. The
work described here used uniform magnetic fields and had poor spatial resolution,
however, in principle it is possible to improve the resolution either through endoscopy, or
by restricting the region of modulation using appropriately designed magnetic fields and
scanning the field across the sample (e.g., the field orientation and strength changes the
most in the null region between opposing field sources) (82, 83).
In this study, we developed a MagMOON-based sensor film to detect alginate
lyase protease activity based on the release of MagMOONs trapped in an alginate gel.
Alginate was selected as a model system because it is a natural polysaccharide widely
used in biomedical applications, especially in drug delivery, due to its unique properties
such as being biodegradable, injectable and chemically modifiable (53, 54). Monovalent
alginate salts (Na+, K+, NH4+) are soluble in water while the divalent cations (Ca2+, Ba2+,
Sr2+) ionically link the alginate polymer chains together and cause gelation. Therefore,
alginate gels are formed when transforming from the monovalent salt form to the divalent
salt form, and the reverse reaction causes de-gelation. We used a calcium ion solution to
induce gelation of an alginate and MagMOONs mixture. The resulting MagMOON-
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trapped calcium alginate gel then was used as a sensor for detecting alginate lyase, the
protease of alginate that cleaves the 1-4 O link between monomers of the alginate chain
(84). As the bonds are cleaved, MagMOONs are released from the gel matrix and become
free to rotate. Each individual MagMOON can be tracked based on its blinking signal
under the magnetic modulation. Therefore, the activity of alginate lyase is indicated via
MagMOONs blinking signal. The technique we use in this study can also be applied in
other biosensors and drug delivery systems based on enzyme-catalyzed breakdown of gel
components.
Method and Experimental Setup

The 4.8 µm fluorescent Nile Red carboxyl ferromagnetic particles were provided
by Spherotech (Spherotech, Lake Forest, IL). The particles were comprised of a
fluorescent polystyrene core and a shell containing ferromagnetic chromium dioxide
nanorods. Modification of these particles into MagMOONs was described in previous
papers (49, 50, 85, 86). Briefly, 15 µL of 4.8 µm ferromagnetic fluorescent particles 1%
w/v dispersion in water was mixed with 240 µL ethanol using a vortex mixer, deposited
evenly onto six 25 mm-coverslips, and allowed to dry. A layer of aluminum was
deposited onto the coverslips using an Auto 306 (BOC Edward, West Sussex UK)
thermal vapor deposition system. During this process, aluminum vapor from a heated
tungsten boat travels ballistically through vacuum to coat the glass coverslips as well as
the top hemisphere of the fluorescent particles on the coverslip. The thickness of the
aluminum layer was measured during deposition using a 6 MHz quartz crystal
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microbalance; deposition was stopped at 70 nm. The hemispherically coated
MagMOONs were magnetized in a uniform field so that the magnetic moment of all
MagMOONs pointed in the same direction (towards the coating); (Fig. 2.1a-d). The
particles were then removed from the coverslip and suspended in alginate solution as
described below.
An air core solenoid with 24 mm hole diameter, 35 mm height, and 210 turns of
26 gauge magnet wire served as an electromagnet generating a magnetic field of ~ 0.5
mT at the centre of the microscope stage when powered with 0.25 A and 1 V. To
modulate the MagMOONs, it was programed to switch the field from North-facing to
South-facing every 5 s (for the gelation by calcium and de-gelation by ammonium) or 2 s
(for all other experiments). This relatively long modulation time with the 0.5 mT applied
field was used to provide enough time for all free particles to orient, especially to
minimize read noise when extracting the modulated spectrum from the background. In
the future we will design a system with photomultiplier tubes to collect light from a
larger field of view than the microscope, which is expected to improve signal to noise
ratios and allow more rapid detection with less read noise. Fig. 2.1e illustrates the
working principle. In an oscillating external magnetic field, the MagMOONs appear to
blink as they turn from a dim orientation, with the metal-coated side facing the objective,
to the bright orientation, with the uncoated fluorescent side facing the objective. This
blinking signal can be separation from un-modulated backgrounds by filtering the signal
at the driving frequency (85). Fig. 2.1g shows an example of two single MagMOONs
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rotating and blinking. About 30 s after adding CaCl2 0.1 M (75 s after the start of the
experiment), the rotation stops as the gel forms.
Alginate lyase from Sphingobacterium multivorum, powder, >10,000 units/g solid
was purchased from Sigma Aldrich (Sigma Aldrich, St. Louis, MO) and freshly made
into 4 mg/mL solution in distilled water. NH4Cl and CaCl2 were purchased from Acros
Organics (Acros Organics, Morris Plains, NJ) and were made into 2 M and 0.2 M
solution, respectively. Sodium alginate was purchased from Alfa Aesar (Ward Hill, MA)
and was freshly dissolved in distilled water to make a 10 mg/mL solution. This solution
(20 µL) was pipetted on a coverslip with freshly prepared MagMOONs after coating via
aluminum vapor deposition and magnetizing (see previous paragraph). The area in the
drop was scraped either with a pipette tip following by pipetting the MagMOONsalginate mixture and disperse in sodium alginate 10 mg/mL with the ratio of 70 µL
sodium alginate 10 mg/mL per coverslip, or a camel hair #0 paintbrush following by
sonication of the paintbrush in sodium alginate. The MagMOON-sodium alginate
mixture (10 µL) was then spread onto a 25 mm-coverslip that was previously cleaned by
plasma-etching with a Harrick plasma cleaner (Harrick Plasma, Ithaca, NY) and 20 µL
CaCl2 0.2 M was dropped on top of the mixture to form a ~ 100 µm thick calcium
alginate gel with MagMOONs. The gel was left for 5 minutes before gently washing with
distilled water. The coverslip was then left to dry under ambient conditions for 30
minutes before imaging. The particle concentration in the formed gel was estimated to be
~ 5 x 104 particles/mL. To determine whether the MagMOON concentration within the
film was uniform, we counted the number of particles in several images of a thin film gel
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made between two cover slips (0.35 mm in thickness and 15 mm in diameter). We
examined 36 fields of view (690 µm x 517 µm) and counted 63 ± 17 particles per field
view. The standard deviation is approximately twice what we expected from Poisson
statistics, indicating that although the distribution appears random within an image, there
is some heterogeneity in concentration across the film. Fig. 2.1h shows a representative
image of particle distribution in a field view.
Fig. 2.1f is a schematic of the microscope setup. A Leica DMI5000 epifluorescence microscope (Leica Microsystems, Bannockburn IL) with a 10x, 0.3 NA
objective lens was used for all experiments. For SPT experiments, the sample was
illuminated using blue light excitation from a filtered mercury lamp and images were
continuously acquired every 1 second (0.2 s exposure time) using ORCA- Flash 2.8
CMOS camera and HCImage software (Hamamatsu, Bridgewater, NJ). The fluorescent
intensity was exported and analyzed using a SPT script in Matlab program. For
measurements through tissue, a 50 mW Ar-ion 514 nm laser was used as the excitation
source. The emission signal was collected in an epi-fluorescence configuration using
DNS 300 spectrometer (DeltaNu, Laramie, WY) equipped with an Andor DU420A-BV
CCD camera and Andor software (Andor Technology, South Windsor CT) with an
acquisition time of 0.2 s per spectrum.
For SPT, custom Matlab scripts were written to extract from the acquired
fluorescence movies the position and fluorescence intensity of single particles in time
(Appendix C). The particle position was determined from the intensity centroid within a
region around the particle, after applying a threshold to remove background signals. The
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total intensity of the tracked region was also recorded. Although all particles in view
could be tracked simultaneously, to ensure comparable data, we selected for tracking only
particles that were well separated (more than 2 particle diameters), and stayed in the field
view and within a certain range of focus. In addition, we removed a few rare particles that
didn’t blink (either because they were uncoated or stuck to the glass), or had paths that
crossed each other. Using these selection criteria, on average ~ 50% of the particles in
view were trackable.
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(h)

Fig. 2.1. Experimental setup. (a)-(d) Fabrication process: (a) 4.8 µm fluorescent ferromagnetic
microspheres deposited on a glass coverslip. (b) Microspheres magnetization. (c) Metal (Al, Au, or Ag)
vapor deposited onto one hemisphere of the microspheres. (d) SEM image of a Fe3O4 MagMOON. The
arrow points to the Au-coated side. (e) Working priciple: MagMOONs blink when they rotate in response
to rotating magnetic field. (f) Schematic of fluorescence micoroscopy setup. (g) Two single MagMOONs
blinking before and after 0.2 M CaCl2 addition to 10 mg/mL alginate (at ~ 75 s). Insets show one frame
where both MagMOONs are bright, and one frame where one MagMOON is trapped in the dim orientation.
(h) Representative fluorescence image of MagMOONs in a gel for determining particle distribution.
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For experiments performed through tissue, we collected the fluorescence spectra
as a function of time during modulation. We then calculated the average intensity from
544 nm to 867 nm (just past the long-pass emission filter to the last pixel in the spectrum)
in order to increase the signal to noise ratio for studying the blinking waveform over
time.
For the experiment on de-gelation by NH4Cl, the prepared coverslip with
MagMOONs-trapped calcium alginate gel was put in an open on-stage chamber. Distilled
water (400 µL ) was added to the chamber, forming a ~ 1 mm thick water layer above the
gel. During the acquisition, an additional 400 µL NH4Cl 2 M was added by pipette to
cause de-gelation.
For the experiment on de-gelation by alginate lyase, the prepared coverslip with
MagMOONs calcium alginate gel was pre-incubated in 400 µL distilled water at 37 °C
for 10 min. During the acquisition, 400 µL alginate lyase 4 mg/mL was added to cleave
the calcium alginate matrix.
To detect the effect of alginate lyase on calcium alginate matrix through tissue,
the prepared calcium alginate thin film coverslip was placed in a chamber embedded with
square slices of chicken breast (Tyson Foods Inc., Springdale AR), 2.5 x 2.5 inches,
wrapped in clear plastic. The top chicken slice was about 1 cm thick while the bottom
slice was varied from 1 mm to 6 mm. In the control test alginate lyase was denatured by
boiling for 30 minutes. The alginate lyase was added right before placing the top tissue
slice and starting the acquisition.
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Results and Discussion

To induce de-gelation of the calcium alginate gel, we used two approaches, as
shown in Fig. 2.2. First, we added ammonium ions to the gel to compete with and replace
the cross-linked calcium ions in the calcium alginate gel. Second, we applied alginate
lyase to the gel to cleave the glycosidic 1 à 4 O-linkage between monomers of the
alginate chain and cause gel destruction. In both cases, initially trapped MagMOONs
became free to rotate and blink along with the external magnetic field. We could
effectively monitor the de-gelation process by tracking the position of single
MagMOONs or the total intensity change under magnetic modulation.
NH4
+

Ca

2

B

+

MagMOONs in sodium
alginate solution

MagMOONs in calcium
alginate matrix

Alginate
Lyase

B

Fig. 2.2. Summary of gelation and de-gelation experiments.

We also demonstrated the ability to track through tissue the modulated
fluorescence intensity from an ensemble of MagMOONs. The calcium alginate gel with
entrapped MagMOONs was placed between two slices of chicken breast and a 514 nm
laser excited the fluorescent signal from MagMOONs. The modulated signal decreased
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dramatically with the increase of tissue thickness but was clearly identified through up to
4 mm tissue.
Monitoring de-gelation by tracking individual MagMOON motion
Alginate includes mixed polymer chains of different arrangements of α-Lguluronate (G), and β-D-mannuronate (M) monomers. In sodium alginate, –COOH
groups are partly replaced by –COONa (87, 88). Alginate gels form in the presence of
divalent ions such as Ca2+ and dissolve when monovalent ions such as NH4+ displace the
divalent ions. The calcium alginate gel structure is maintained by the coordination of
Ca2+ with oxygen atoms in a cavity created by a pair of guluronate sequences along
alginate chains. According to the literature, during gelation, egg-box like dimers form
first and then laterally associate to form egg-box multimers (89). Unlike divalent cations,
monovalent ions such as Na+, K+, Li+ or NH4+ cannot serve as crosslinkers between
guluronate sequences, hence the displacement of Ca2+ ions by NH4+ ions destroys the
gels.
In our experiments, we tracked the position and intensity of MagMOONs in a
calcium alginate gel as a function of time during de-gelation. To destroy the gel structure
and cause de-gelation, we added NH4Cl 1 M to calcium alginate gel to replace Ca2+ ions.
Fig. 2.3a shows the background-corrected fluorescent intensity as well as x- and ydisplacements of a representative MagMOON. At the beginning when the MagMOON
was fixed in the gel, its intensity remained unchanged with time because the gel
prevented it from rotating. After about 4 minutes, enough ion replacement had occurred
to release the MagMOONs from the matrix and the MagMOON fluorescence began to
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blink in response to the oscillating magnetic field. During the de-gelation process, the
amplitude of the modulation increased, presumably due to the gradually release of
MagMOON from the matrix as the polymers were cleaved. We used a low magnification
objective to observe many particles simultaneously, which made it difficult to accurately
discern the shape of the fluorescent crescent as the MagMOON rotated. However, the
shape could be discerned well enough to determine that after ~ 320 s, the MagMOON
was almost fully modulated (fully bright to fully dim).
To compare the de-gelation behavior of multiple particles with different volumes
and fluorescence intensities, we defined the “de-gel time” as the point when the
modulated amplitude reached 20% the maximum amplitude. We removed from analysis
particles that clearly moved out of focus before fully modulating. The de-gel time of the
MagMOON in Fig. 2.3a was determined to be ~ 300 s, as measured from its short-time
Fourier transform spectrogram (Fig. 2.3c, d). Fig. 2.3b shows the position tracks of four
individual MagMOONs in the observation view (including the representative one in Fig.
2.3a). The initial position is marked with a black star, and the position at the de-gel time
is marked with a colored dot (with the color indicating the de-gel time). Plotting the
displacements and de-gel time together revealed interesting information about the
heterogeneity of the de-gel process. First, it is clear that the particles followed almost the
same path, indicating that the entire gel flowed together in this region. Second, there was
significant heterogeneity in de-gel time, with one of the four particles (yellow spot)
taking twice as long to blink as the other three and moving about 20 µm before it blinked.
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Fig. 2.3. Tracking individual MagMOONs to detect alginate de-gelation by ammonium ion replacement.
Intensity and x, y-displacements of one representative MagMOON are plotted in (a): x-displacement (blue
line, left y-axis), y-displacement (red line, left y-axis) and fluorescence intensity (green line, right axis).
Modulation is seen after about 300 s. (b) The plot of de-gel time (color-coded spots) with x, ydisplacements for single MagMOONs to show different MagMOONs in the same field view de-gelled at
different time. The MagMOONs plotted in (a) are marked in blue boxes in (b). Black stars (*) indicate the
initial MagMOON position. The short-time Fourier transform (27 windows, each 23 s long) spectrogram
shows MagMOON modulation after ammonium addition: (c) Spectrogram of relative Fourier component
amplitude (log scale, color-coded) as a function of frequency and time. (d) Plot of Fourier component
amplitude in time at the driving frequency (0.02 Hz) and two other non-modulating frequencies.
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Having successfully tracked MagMOONs during de-gelation by ammonium ions,
we next used the MagMOON-trapped calcium alginate gel to detect de-gelation from
alginate lyase activity. Alginate lyase catalyzes alginate degradation by cleaving the 1-4
O linkage between monomers (84). As the chains are cleaved, MagMOONs are released
and become free to rotate with the magnetic field. We pre-incubated the prepared
MagMOON-calcium alginate gel coverslip in 400 µL distilled water at 37 °C for 10
minutes before acquisition. During the acquisition, 400 µL alginate lyase (4 mg/mL) was
added to cleave the calcium alginate matrix. Fig. 2.4a shows the x, y-position and
background-corrected intensity of a representative MagMOON immediately following 2
mg/mL alginate lyase addition. The MagMOON started to move laterally after around
350 s, as indicated by the increasing slope of x and y-displacements; however this lateral
motion was not yet accompanied by fluorescence blinking. After ~600 s the MagMOON
began blinking while simultaneously moving. In this case, plotting the intensity change
together with the x and y-displacements elucidates the 2 steps (lateral moving without
blinking first and then moving with blinking) of the de-gelation process observed. The
motion during both steps was directed rather than diffusive, suggesting that as the
alginate gel disintegrated, convection currents were generated before particles were
released and able to rotate and blink. By tracking modulation of the MagMOON
intensity, MagMOON rotation was detected independently from this convective
transport.

33

(b)
500
450

y-displacement (µm)

400
350
300
250
200
150
100
50
100

200

300
400
x-displacement (µm)

500

Fig. 2.4. Tracking individual MagMOONs to detect alginate de-gelation by alginate lyase. Intensity and x,
y-displacements of one representative MagMOON are plotted in (a) - alginate lyase: x-displacement (blue
line, left y-axis), y-displacement (red line, left y-axis) and fluorescence intensity (green line, right axis). (b)
De-gel time (color-coded spots) with x, y-displacements of single MagMOONs. The MagMOON plotted in
(a) is marked in blue box in (b). Black stars (*) indicate the initial MagMOON position. (c) Presentation of
the de-gelation process in a field view with 31 MagMOONs by plotting their x and y-positions with their
de-gel time (color-coded). The de-gel time increased from the left to the right side of the figure indicating
the de-gelation occurred gradually from the left to the right. The average de-gel time was 474 ± 18 s. (d)
Plot of the average intensity of 31 MagMOONs (green line) and average intensity of the whole field view
(blue star line). The intensities were normalized to aid comparison. The de-gel time determined by the
average intensity of these 31 particles agrees with that generated from the average intensity of the whole
field view.
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The variation in de-gel time after adding alginate lyase is also presented in Fig.
2.4b. The color distribution indicates the de-gelation occurred from the top-left corner
first then it went down on the left before spread out to the right. From the data in Fig.
2.4b, one can tell that all five particles have similar movement. This observation fits well
with the previous discussion of Fig. 2.4a about convection current and suggests that the
whole gel flowed over the cover glass before the MagMOONs became free to rotate. An
advantage of using MagMOONs over un-modulated probes is that MagMOON
orientation could be tracked based on their blinking signal even when the gel moves.
Although these experiments tracked the intensity change from each MagMOON,
all the MagMOONs responded in a similar time frame and the rotation was synchronized
to the driving field, thus the average de-gelation time can also be obtained from the
ensemble average intensity. To characterize the process of de-gelation by alginate lyase, a
total of 31 particles in a field of view were tracked using our particle tracking algorithm.
The algorithm calculated x, y-displacements, intensity and de-gel time (defined as 20% of
maximum modulation). All the experiment parameters were the same as in Fig. 2.4a and
b. Fig. 2.4c shows the de-gel time distribution across the field view. The average de-gel
time was 474 ± 18 s. Much of this variation appears co-ordinated, with shorter times on
the left than the right of the view. Fig. 2.4d shows that the average de-gel time
determined by the average intensity of these 31 particles also agreed with that generated
from the average intensity of the whole field of view.
The above tests demonstrated a simple way to detect the de-gelation process using
MagMOON modulation. The MagMOONs probed both the local and overall behavior of
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the de-gel process. In additional experiments, we moved a step further by testing the
detection ability through different thicknesses of chicken breast. Although the position of
individual particles cannot be detected through thick tissue, the total blinking signal from
many particles can.
De-gelation tracking through tissue
Unlike conventional fluorescent dyes, untethered MagMOONs emit modulated
fluorescence intensity in response to a rotating external magnetic field. This blinking
property distinguishes the MagMOONs signal from the tissue autofluorescence
backgrounds. To determine if the blinking MagMOON signal could be detected through
tissue, we placed a film of MagMOONs in a temperature-controlled chamber between
two slices of chicken breast, 1 cm thick on top (to limit light escaping) and various
thicknesses of 1 mm, 1.5 mm, 2.5 mm, 4 mm, and 6 mm at the bottom. During the
acquisition, the temperature was maintained at 37 °C for fast and efficient enzymatic
activity of alginate lyase (90). Fig. 2.5 shows the experimental setup schematic (a) and
picture (b). As mentioned in the Experimental section, we used a 514 nm laser at the
power of ~ 50 mW as the excitation source and the emission signal was collected using a
spectrometer. Although the background from tissue autofluorescence was high, the
modulated probe spectrum can be revealed by subtracting the average signal in the dim
orientation from the average signal in the bright orientation (Fig. 2.5c).
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Fig. 2.5. Fluorescent imaging through turbid chicken breast tissue. (a) Schematic of the setup for magnetic
modulation and imaging through tissue. The MagMOONs are trapped in alginate calcium gel on a coverslip
in an on-stage incubator chamber. This chamber is embedded in the chicken breast tissue. An
electromagnet was used to modulate the MagMOONs. (b) Photo of the experimental setup. (c)
Representative fluorescence spectra of MagMOONs embedded beneath 1 mm tissue, acquired after degelation. ON and OFF is the average signal when the MagMOONs face the uncoated side and coated side,
respectively, to the objective lenses. The inset figure shows the zoom-in of the ON minus OFF modulated
signal.

To ensure that only active alginate lyase caused de-gelation, a control experiment
was conducted using denatured lyase. Alginate lyase was denatured by boiling for 30
minutes before adding to the gel, followed by water addition to confirm that denatured
lyase did not cause MagMOONs to become free to rotate. After performing these
denatured lyase controls, active alginate lyase was added at 36 minutes, which caused degelation. Fig. 2.6a shows the intensity change with time of MagMOONs through 3 mm
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chicken breast during four stages of the experiment. Stage 1: During the first 7 minutes of
the acquisition when calcium alginate gel was covered by a 100 µm water layer, the
fluorescence from the sample (tissue containing MagMOONs) bleached quickly with no
evidence of modulation. Stage 2: Throughout the 20 minutes after denatured alginate
lyase addition, there wasn’t a significant change except for the short term restoration of
background fluorescence, likely due to small shift in tissue position directly in the laser
beam, followed by approximately exponential slowdown bleaching. Stage 3: The same
situation occurred after denatured alginate lyase removal and water addition. Stage 4:
After addition of 2 mg/mL alginate lyase, strong MagMOON modulation was observed at
the driving frequency. A short-time Fourier transform was applied to the intensity-time
series to clearly present the MagMOONs modulation before and after alginate lyase
addition (Fig. 2.6b). Stage 4 clearly shows modulation at the driving frequency of 0.25
Hz, as well as higher frequency harmonics arising from driving the modulation with a
square-wave modulated magnetic field. For clarity, Fig. 2.6c shows the intensity of 3
represented frequencies, of which one is corresponded to the modulated frequency and
two nearby frequencies (0.22 and 0.45 Hz). The strength of the 0.25 Hz frequency
component is clearly higher than the background at 0.22 and 0.45 Hz.
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(b)

Fig. 2.6. Monitoring of MagMOON modulation through tissue after adding denatured and active
alginate lyase to the alginate gel. a) Magnetically modulated fluorescence signal through 3 mm of chicken
breast using 514 nm green excitation laser during 4 stages: Stage 1: alginate gel in water; Stage 2: after
adding denatured alginate lyase; Stage 3: after denatured alginate lyase removal and water addition; Stage
4: after 2 mg/mL alginate lyase addition. Modulation can be seen during Stage 4. Inset figures are zoom-ins
to show modulation if present. b, c) Short-time Fourier transform spectrogram shows modulation after
alginate lyase addition but not after addition of water or denatured alginate lyase.
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Having successfully detected alginate lyase activity through 3 mm of chicken
breast, we next studied how tissue thickness affected signal intensity. The setup was the
same as shown in Fig. 2.5 and the results are presented in Fig. 2.7. In Fig. 2.7a, the
fluorescent signal through 2.5 mm tissue is plotted with a smoothed curve of the original
data. After subtracting with the smoothed curve to take into account for the bleaching
background, the modulated and background-corrected signals through 1 mm, 1.5 mm, 2.5
mm, 4 mm and 6 mm are presented in Fig. 2.7b,c. Although the amplitude of modulation
decreases dramatically with the increase of the tissue thickness, the modulation is clear
through up to 4 mm (see the inset figure of Fig. 2.7c). We used short-time Fourier
transform to elucidate the de-gel points (Fig. 2.8) and obtained the values of about 5, 10,
11 and 7 minutes following lyase addition through 1 mm, 1.5 mm, 2.5 mm and 4 mm
tissue, respectively. This time range agrees with the SPT results, where modulation can
be seen after 5 - 12 minutes (data not shown). Most of this variation is likely due to subtle
differences in gel preparation. As prepared, the gel system is able to detect alginate lyase
at 2 mg/mL or 60.6 µM concentration (given the molecular weight of alginate lyase is 33
kDa (90)) in 10 minutes. Fig. 2.7d shows the signal to baseline noise ratio as a function of
tissue depth, where the signal is defined as the difference between the 0.25 Hz Fourier
series coefficient after de-gelation and at the start of the experiment (while the
MagMOONs were still entrapped), and the baseline noise is defined as the standard
deviation of the 0.25 Hz Fourier series coefficient at the start of the experiment. The
signal-to-baseline-noise ratio decreases by approximately one order of magnitude per
millimeter of tissue depth; we expect it can be improved by acquiring signal over longer
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periods of time (e.g. using a longer window in the short-time Fourier transform), using
red-excited fluorophores, increasing the optical collection efficiency with a large area
photodetector in place of the narrow-slit spectrometer, increasing the number of
MagMOONs, or mechanically compressing the tissue). Nonetheless, the study confirmed
that the MagMOON signal could be tracked through tissue to detect the presence of
alginate lyase.
Fig. 2.8 shows the 3-D plots of relative Fourier component amplitude (log scale,
color-coded) as a function of frequency time for all studied tissue thickness (a) and
corresponding plots of relative Fourier component amplitude in time at the driving
frequency (0.25 Hz) and two non-modulating frequencies (b). Modulation can be seen
after 5, 10, 11 and 7 minutes with 1 mm, 1.5 mm, 2.5 mm and 4 mm tissue respectively.
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Fig. 2.7. Detection through tissue the de-gelation by alginate lyase. (a) Plot of fluorescence signal
through 2.5 mm chicken breast and its smoothed curve. (b) Background-corrected magnetically modulated
fluorescence signal through 1 mm, 1.5 mm, 2.5 mm, 4 mm and 6 mm chicken breast. (c) Zoom-in of (b) to
visualize modulation. The inset figure is a more zoomed-in of the 4 mm tissue thickness case for clarity. (d)
Signal to baseline noise ratio for MagMOONs viewed through different tissue thicknesses, based upon
Fourier analysis in Fig. 2.8.
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Fig. 2.8. Short-time Fourier transform analysis to detect blinking through tissue. Short-time
Fourier transform spectrogram (73 windows, each 23 s long) of fluorescent intensity through 1 mm, 1.5
mm, 2.5 mm, 4 mm and 6 mm tissue (from top to bottom) following alginate lyase addition. Modulation is
evident through up to 4 mm tissue. (a) 3-D plot of relative Fourier component amplitude (log scale, colorcoded) as a function of frequency time. (b) Plot of relative Fourier component amplitude in time at the
driving frequency (0.25 Hz) and two non-modulating frequencies. Modulation can be seen after 5, 10, 11
and 7 minutes with 1 mm, 1.5 mm, 2.5 mm and 4 mm tissue respectively.
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Conclusions and Future Work

We developed a simple yet novel means to detect alginate lyase activity based
upon the change in MagMOONs modulation in alginate gel before and after alginate
lyase addition. The blinking MagMOON signals can be observed through tissue and
separated from autofluorescence. Although we only detected through 4 mm of tissue, we
used a microscope-coupled spectrometer with very small optical collection efficiency due
to the small field of view and numerical aperture. In future, we plan to use large-area
photomultiplier tubes with a lock-in amplifier for more sensitive measurements in thicker
tissue. For single particle studies in situ, an endoscope will be used to collect fluorescent
signals from MagMOONs through tissue. This approach could also be expanded to redexcited fluorescence, X-ray excited optical luminescence (91), and SERS (92).
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CHAPTER THREE
TRACKING ANISOTROPIC OPTICAL TRACERS (MOONS) TO STUDY
INTRACELLULAR TRANSPORT AND CYTOTOXICITY

Introduction

This section will start with a short introduction of macrophages, cytoskeletal
structure and protein motors. The roles of intracellular transport and related diseases are
then presented, following with a brief review of intracellular transport study. Finally, the
cytotoxicity of three cytoskeletal drugs used in this study: cyanide, azide and 2-deoxy-Dglucose will be summarized.
Macrophages
Macrophages are phagocytic cells that keep the body clear of intruding foreign
matter. They originate from hematopoietic stem cells in the bone marrow. Lung
macrophages include pleural, intravascular, interstitial and surface (airway and alveolar)
macrophages. Among them, the surface macrophages are exposed to the environment the
most and hence are the first barriers of the defense system, with the function of engulfing,
transport and clearance of particulate matter entering via the respiratory tract (93). The
mechanisms of these particles to enter cells (endocytosis processes) can occur through
pinocytosis, micropinocytosis and phagocytosis; particles larger than 250 nm in diameter
are generally taken up by phagocytosis. Phagocytosis can be non-specific or receptormediated (e.g., mediated via binding of cell receptors to complement molecules adsorbed
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onto the particle surface or Fc regions of antibodies bound to the surface) (94).
Phagocytosis and mucociliary transport are the two main processes for lung clearance of
particulate matters (95). Swanson reviewed the steps for phagocytosis: first, a particle
binds to the cell membrane by either mediated receptors or electrostatic forces. Then the
transfer signal is activated, following by actin functioning. Finally, a closed vesicle is
formed over the particle (96). The uptake is often completed within a day (97). Once the
particle is bound to the receptor, intracellular signaling activates actin polymerization and
coordinates cytoskeletal movements (98). From here, the intercellular transport of the
phagosome (vesicle of the particle) is carried on by protein motors along microtubules.
The phagosome then is fused with lysosome where the particle is digested with lysosomal
hydrolyses (94). Among these steps, intracellular transport requires the involvement of
cytoskeletal structures and protein motors.
Cytoskeletal structures and protein motors
Microtubules, microfilaments (or actin filaments) and intermediate filaments are
the main components of the cytoskeletal structure. Their important roles include cell
structural support, movement and transport. The structures of these cytoskeletal filaments
are well summarized by Alberts and others (99). Briefly, microtubules are long hollow
cylinders of about 25 nm in diameter, composed from α- and β-tubulin proteins and
arranged from the nucleus toward the cell membrane. Microfilaments are two-stranded
helical polymers of actin protein with diameter of about 7 nm, distributed in abundance
beneath the plasma membrane throughout the cell. Intermediate filaments are about 10
nm in diameter and made of different types of proteins. They help resist mechanical
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stress, like the springs of a mattress. These cytoskeletal filaments are like the roads of a
city although only intermediate filaments are more stable structures, whereas
microtubules and actin filaments are dynamic and can be re-structured quickly.
Intracellular transport on these roads is carried out by dozens of motor proteins including
myosins, kinesins, and dyneins. Myosins are actin-based motor proteins that move along
actin filaments. Among them, myosin II is well-known and the first identified to generate
force for muscle contraction (100), while myosin V plays roles in organelle and vesicle
transport (101). Dyneins and kinesins are two types of motor proteins that transport
organelles along microtubules (102). Most kinesins have binding sites for membraneenclosed organelles or for other microtubules (103). Cytoplasmic dyneins are responsible
for vesicle trafficking (104) and axonemal dyneins can move the microtubules at a very
fast speed (105).
Roles of Intracellular Transport and Related Diseases
As mentioned in the macrophages section, intracellular transport is essential to
ensuring the regular functions of the cellular machinery by trafficking and delivery of
proteins and molecules to their functional locations in cells (94). Disruption of this
transport may lead to many diseases as described in (106, 107). Some examples are cystic
fibrosis lung disease in which, due to mutations of the cystic fibrosis, transmembrane
regulator (CFTR) gene is not transported to the right cellular location (108); and a
number of neurondegenerative diseases associated with axonal transport damage such as
Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS) (109,
110). There are also illnesses related to viral trafficking (hijacking), where viruses such
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as HIV use intracellular transport networks to invade nucleus (111, 112), or to survive
and replicate while avoiding immune system responses, such as Salmonella enterica
(113). Studying intracellular transport, therefore, is important to elucidate the
mechanisms of these diseases and possibly guide therapeutic solutions.
Study of intracellular transport
Beside the need to know what cell compartments participate in intracellular
transport, it is even more important to know how they function. Often, the structures
involved in transport are not visible under light microscopy because their sizes are below
the resolution limit. For instance, vesicle size is around 3 -200 nm, and microtubule size
is about 25 nm. Hence, the understandings of intracellular transport have tightly bound
with the development of the microscopy and staining techniques. (114-116). In 1665
Hooke described in details many small objects in the micrometer size range that are
invisible to the naked eye, including cells from a cork, using a microscope (117). Cell
morphology was widely explored in the nineteenth century (115) but cell physiology
describing the intracellular dynamic interactions, including intracellular transport studies,
only bloomed in the twentieth century with the development of live-cell imaging
techniques such as phase-contrast microscopy (118), polarization microscopy (119), and
video-enhanced differential-interference contrast microscopy (120, 121). Inoué described
the change of mitotic spindle and chromosome movement by microtubules during mitosis
using polarized microscopy in 1953 (119). With video-enhanced differential-interference
contrast microscopy (VE-DIC) the marine protist Allogromia dynamic microtubule
movement and the fast transport along microtubules in squid axon was observed by Allen
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and colleagues in 1981 and 1982, respectively (120, 121). Salmon (122) reviewed the
important role of VE-DIC in the discovery of cytoplasmic protein motor kinesin in 1995.
Exploration of the microscopy techniques, especially particle tracking, has
enhanced greatly the understandings of intracellular transport mechanisms. The trajectory
of a tagged tracer on a vesicle, an organelle, a protein motor, or a skeletal structure is
followed, and parameters such as moving velocity, MSD and correlation coefficient are
widely used to characterize intracellular transport motion. Since the late 1900s
researchers started to describe in more detail the intracellular transport process. Axons
were the popular choice for intracellular transport study due to their fast transport (1-5
µm/s) of organelles and molecules over long distances (123). An in vitro test on isolated
axonal filaments showed organelles of different sizes moved continuously along the
filaments with the same velocity of ~ 2 µm/s. Meanwhile, in intact axoplasm organelles
moved discontinuously and the speed was size-dependent, with the larger organelles
(such as mitochondria) moving at a slower rate than smaller vesicular organelles (124).
These results implied the existence of a highly interconnected filament system in
cytoplasm that hinders large organelles more than smaller ones. In a review in 1987, Vale
listed the velocity of movement (µm/s) of different motility proteins as: skeletal muscle
myosin (2-5); Acanthamoeba myosin I (0.03); ciliary dynein (10); cytoplasmic dynein (1)
and kinesin (0.5). Here we can see that the moving velocity can be up to 3-fold different,
depending on the type of motor.
Allan and colleagues (125) described in detail quantitative results on early
endosome transport by SPT. They divided the tracers’ motions into two groups, run and
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rest by the thresholds of moving rate of 0.17 µm/s and moving length of 85 nm. Motions
with higher numbers than these thresholds are defined as runs while lower ones are rests.
By these definitions, they claimed, on average, endosomes in HeLaM cells run for 22%
of total time; with 65% of a total of 1800 labeled endosomes having at least 1 run during
data collection. Treatment with nocodazole to depolymerize microtubules caused no
observed linear movement, suggesting all runs were along microtubules. They also
reported the fastest observed speed was 8 µm/s while the corresponding estimated value
in mammalian cells was ~ 4-5 µm/s according to (126). With the same objectives when
tracking early endosome trafficking on human epithelial cells, Holzbaur and others (127)
had a different motion classification. First, they classified the motions into three
categories: directed, diffusive and confined, instead of two. Directed motion moved faster
than 1 µm/s and the confined motion moved less than 0.5 µm. The classification was
based on the scaling exponent α value, obtained form fitting the MSD with Equation 2.
MSD = <r2> = 4Dtα + 2σ2, (Equation 2)
where D is the diffusion coefficient, t is the time lag, and σ is the measurement error.
Motion with α > 1.45 is directed, α < 0.4 is confined, and in the middle range is diffusive.
They found that 59% of motions are confined; 39% are diffusive (at pauses) and only 2%
are directed. They also found that during the transition time before and after a directed
run, the motion is diffusive. In 2012, the Fang group published their study on axonal
transport with nanorod rotational tracking. They found that the nanorod orientation was
maintained during the active transport. They also observed long pauses and short pauses
of the transport where the long pauses were associated with rotation. Moreover, 76% of
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long pauses with rotation were followed with a direction reversal. This indicated there
might be uncoupling and reattachment of motors during long pauses in preparation for
the change in direction (128). These findings emphasized the extended information
provided by the rotational tracking in compliment with translational tracking. Therefore,
we expect our rotational and translational tracking method will reveal useful information
about intracellular transport that can be used to evaluate cytotoxicity. To test this
hypothesis, we will use cytoskeletal drugs – 2-deoxy-D-glucose with either cyanide or
azide to inhibit intracellular motion. The toxicity mechanism of these compounds is
described in the following section.
NaCN, NaN3 and 2-deoxy-D-glucose toxicity
As tracers are phagocytized, phagosomes containing these tracers are formed and
transported within cells by molecular motors that move along cytoskeletal structures
(e.g., myosin V moves along actin filaments). This motion can be inhibited by depletion
of ATP production. NaCN or NaN3 are toxins that reduce ATP production by inhibiting
electron transport when binding to the cell’s cytochrome oxidase complexes (129).
Meanwhile 2-deoxy-D-glucose, with a similar structure to glucose competitively inhibits
glycolysis and therefore stops the free energy generation required for ATP synthesis
(130). The combination of these two inhibitors was reported to cause a huge depletion of
ATP production compared to separate use (131-133). This energy depletion in turn has a
significant effect on macrophage transport. We use both inhibitors as a positive control
for the cytotoxicity assays.
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Method and Experimental Setup

MOONs preparation
The 520 nm fluorescent Dragon Green particles were purchased from Bangs
Laboratories (Bangs Laboratories, #SF03F, Inc., Fishers, IN). The particles comprised
Dragon Green fluorescent dye (480, 520) entrapped in polystyrene beads. Modification of
these particles into MOONs is similar to that described in Chapter Two. Briefly, 10 µL of
520 nm fluorescent particles 1% w/v dispersion in water was mixed with 240 µL ethanol
using a vortex mixer, deposited evenly onto six 25 mm-coverslips, and allowed to dry. A
layer of aluminum was deposited onto the coverslips using an Auto 306 (BOC Edward,
West Sussex UK) thermal vapor deposition system. During this process, aluminum vapor
from a heated tungsten boat travels ballistically through vacuum to coat the glass
coverslips as well as the top hemisphere of the fluorescent particles on the coverslip. The
thickness of the aluminum layer was measured during deposition using a 6 MHz quartz
crystal microbalance; deposition was stopped at 30 nm. After deposition, 20 µL water
was pipetted on the coverslip with freshly prepared MOONs. The area in the drop was
brushed with a camel hair #0 paintbrush to gently removed particles from the coverslip
surface. The suspension was then carefully transfer into a 1.5 mL centrifuge tube by
pipetting and DI water was added with the ratio of 70 µL per coverslip, followed by
sonication of the paintbrush immerged in the suspension. MOONs from this suspension
were added to the cell medium.
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Chemicals
Sodium cyanide (NaCN), reagent grade, 97% and 2-deoxy-D-glucose were
purchased form Sigma Aldrich (St. Louis, MO). Sodium azide (NaN3) 5% w/v solution
was from BDH (West Chester, PA). For the cytotoxicity experiments, 7.5, 15, 30 or 45
µL CuO 5mM; 62.5 µL NaN3 0.1 M and 62.5 µL 2-deoxy-D-glucose 0.1 M; or 142.8 µL
NaCN 0.05 M and 71.4 µL 2- deoxy-D-glucose 0.1 M were added to 500 µL media
before imaging.
Cell culture
J774A.1 macrophages were purchased from American Type Culture Collections
(ATCC, Manassas, VA). The cells were cultured for 48 hours before imaging in
Dulbecco’s modification of Eagle’s medium, 1X with 4.5 g/L glucose, L-glutamine, &
sodium pyruvate (Mediatech, Inc., Manassas, VA) supplemented with 10% heat
inactivated fetal bovine serum (Thermo Scientific, Logan, UT), penicillin (100 units/mL)
and streptomycin (100 µg/mL). The cells were grown on a 8 well Lab-Tek chamber slide
(#177402, Electron Microscopy Scienes, Hatfield, PA) and maintained at 37 °C, 5% CO2.
MOONs were added in cell wells one day before imaging to ensure most of them were
phagocytized by macrophages by the imaging time (97, 134-136). The MOONs outside
cells were washed away when changing to the new completed DMEM cell medium
before acquisition. For the cytotoxicity experiment, the completed DMEM cell medium
was replaced by Dulbecco’s modification of Eagle’s medium, 1X without glucose, Lglutamine, & sodium pyruvate (Mediatech, Inc., Manassas, VA).
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Live-cell imaging
The microscope setup is the same as described in Fig. 2.1f. A Nikon Eclipse Ti-E
microscope (Nikon Instrument Inc., Melville, NY) with a 10 ×, 0.45 NA objective lens
was used for all experiments. Imaging acquisition was set at binning 1, display (1392
×1040 pixels). While imaging MOONs in cells on the microscope stage, cells were
maintained at 37 °C, 5% CO2 in a chamber of a Live Cell stage top incubator (Pathology
Devices, Inc., Westminster, MD). The sample was illuminated using blue light excitation
from a filtered mercury lamp and images were continuously acquired every 0.2 sec (0.2
sec exposure time) using a CoolSnap HQ2 high sensitivity quantitative monochrome
camera and the Nikon imaging software NIS-Elements (Nikon Instrument Inc., Melville,
NY). Acquired time-lapse images were exported in multi-TIF format and a custom
Matlab scripts were written to extract from the acquired fluorescence movies the position
and fluorescence intensity of single particles in time.
The particle position was determined from the intensity centroid within a region
around the particle, after applying a threshold to remove background signals. The total
intensity of the tracked region was also recorded. Although all particles in view could be
tracked simultaneously, to ensure comparable data, we selected for tracking only particles
that were well separated (more than 2 particle diameters), and stayed in the field view and
within a certain range of focus. In addition, we removed a few rare particles that didn’t
blink (either because they were uncoated or stuck to the glass), or had paths that crossed
each other. Using these selection criteria, on average ~ 40% of the particles in view were
track-able.
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Analysis of Data from Particle Tracking
From thousands of time lapse images we used a custom particle tracking script to
extract x,y-coordinates (trajectory) and intensity of each individual particle at each time
point, and stored them in multi-dimensional arrays as Mx, My and meanI respectively.
These outputs are then be used to calculate various parameters that are meaningful in
characterizing the particle motion. The parameters include mean squared displacement
(MSD), diffusion coefficient (D), velocity (v), and histogram.

Results and Discussion

Rotational and translational tracking of single tracers reveals intracellular
transport mechanisms
The 520 nm Dragon Green fluorescent particles were fabricated into MOON
tracers for rotational and translational tracking. They were added to cell wells 24 hours
before imaging to ensure all MOONs were phagocytosed. Macrophages containing
MOONs were maintained at 37 °C and 5% CO2 during fluorescent imaging for about 5
min with a rate of 5 frames per second. Outputs extracted from the image series include
x, y-coordinates and the average intensity surrounding each MOON at each time point.
Tracking is difficult if the particles’ trajectories cross. Therefore, the particles’
concentration adding to cells was limited so that each cell had about one or two particles.
Fig. 3.1 shows a superimposed image of cells and MOONs where there are not too many
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MOONs in a cell. In addition, by the time of acquisition, there were no particles outside
cells.

Fig. 3.1. Superimposed image of macrophages in transmitted light bright field (gray) and fluorescence from
MOONs (red).

Fig. 3.2 shows the relationship between rotation and translation of an individual
MOON via x, y-coordinates and mean intensity plots. There are 3 types of behaviors
presenting in the MOON’s motions. Type (I) motion has fast and straight position
changing but the change in intensity is not significant, indicating non-rotation when
sliding behavior. This should be the case when the MOON was sliding along a
microtubule. Type (II) motion, on the other hand, has clear changes in intensity but the
position doesn’t change significantly, indicating the rotate-not move behavior. This
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observation is in agreement with the pause periods in Fang’s group study on axonal
transport (128), suggesting a motor switching mode. Notably, after the second rotation
highlighted in the second block of type (II) in Fig. 3.2, the x and y-coordinates started
changing, implying the pause was for tethering the MOON onto a (new) motor. There is
also type (III) when both position and intensity are not changing which could simply be
the case when the particle is resting and not linked to a motor, or the tracking is lost. This
result on tracking a single MOON shows that our approach can obtain similar behaviors
previously reported. Moreover, tracking the rotation and measuring the rotation rate of a
single MOON in a macrophage was also used to investigate the cytotoxicity of cyanide
(Appendix A).
Observation over an ensemble of MOON tracers shows the global characteristics
of that population and can be used to distinguish different populations
The previous section presents single-MOON behavior in a cell. We can
characterize the whole population as well. As an example, we compared the MOONs
motion in cells and in glycerol. Since the motion in glycerol is random, we also simulate
Brownian motion and compare the three results together.
MOONs were dispersed in ~ 80% glycerol and a capillary was filled with
MOONs in glycerol by dipping in the suspension. This capillary was sealed at its two
ends to ensure the system is closed and reaches equilibrium before imaging with the same
conditions as the in cell experiments. For simulated particles, x, y-coordinates were
generated by using random function in Matlab (randn), and the random intensity was
generated by function I = [1+sin (ɵ)]exp[(-x2+y2)/s2], where ɵ is the rotation angle, x, y
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are the displacements and s is the standard deviation. The diffusion coefficient of these
simulated motions is 0.151 (µm2/s).

Fig. 3.2. Position and intensity change of a single MOON particle with time.

From the x, y-coordinates and intensity, we calculated the translational (along the
x-axis, for instance) and rotational (intensity) velocity after every 10 frames (2 s) of eight
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randomly picked MOONs from each data set for comparison of their correlation (Fig.
3.3).
The shape of the scattering plot between intensity change and velocity in cell is
diamond-like (Fig. 3.3a) whereas those of in glycerol and random simulation are oval
Fig. 3.3b and c). The oval shape agrees with random motion. With the diamond-like
shape, there are more data points distributed parallel with x and y-axis and symmetric
around the zero points, implying more cases of either type (I) or type (II) motion, where
the motion in cells is more directed than diffusive. In addition, the amplitude of velocity
and intensity change of MOONs in cell is significantly smaller than that in glycerol.
Hence, the correlation between translational velocity and rotational intensity change can
be an index to characterize a large population.
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Fig. 3.3 Correlation between velocity and intensity change of MOONs in cells (a), in glycerol (b),
and by simulation (c).

Cytotoxicity of 2-deoxy-D-glucose in combination with either cyanide or azide
To validate our method of studying cytotoxicity using rotational and translational
SPT, we used ATP inhibitors to stop the intracellular transport. Before the imaging
acquisition, either NaN3 10 mM and 2-deoxy-D-glucose (10 mM); or NaCN (10 mM) and
2- deoxy-D-glucose (10 mM) were added to 500 µL medium. Both sets of drugs caused
immediate immotile behavior of cells and therefore particles. For simplicity, only the
result with (NaN3 and 2-deoxy-D-glucose) case will be presented and regularly called
“toxin” in this manuscript.
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There were 36 MOONs tracked in the toxin addition case. Their trajectories are
plotted in Fig. 3.4a. These trajectories appear as small dots and the MOONs’ movement
is hardly detected because the toxins inhibited the particles’ motion. For visual
comparison, trajectories of 58 tracked MOONs in cells with no toxin addition as a control
were also plotted (Fig. 3.4b). Although the motion in the control varies among particles,
it is clear that the MOONs’ moving amplitude is larger compared to when toxins are
added. In the next section the quantitative analysis based on mean squared displacement
(MSD) to classify the different types of motion in each sample will be presented.
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Fig. 3.4. Trajectories of MOONs in macrophages with (NaN3 + 2-deoxy-D-glucose) addition (a)
and no toxin addition (b).

Motion classification and quantitative characterization of motion
To quantitatively analyze the motion the MSD was calculated for each subtrajectory extracted from a whole length trajectory of each particle (Matlab script in
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Appendix D) and fit them using a non-linear least-squares data-fitting function in
MATLAB named lsqcurvefit. Based on the results of this fitting, important parameters
such as velocity or the scaling exponent (α) were used to classify different motion types
of each sub-trajectory (Matlab script in Appendix E). The percentage of each type of
motion over all sub-trajectories of a population can be a good indicator to characterize
that population’s properties.
MSD is the average of the squared distances a particle moves over time along its
trajectory. Its formula is given by MSD = <r2> = <(r1 – r2)2>, where r1 , r2 are the
particle’s position after a time lag t (s) and the < > sign indicates an average. MSD is a
very useful tool to characterize particle motions.
The four typical models for motion are directed motion, normal diffusion,
anomalous diffusion, and confined diffusion and each is described by the equations
below, as reviewed in (43).
Directed motion: MSD = 〈r 2 〉 = 4Dt + v 2t 2 (Equation 3)
Normal and anomalous diffusions: MSD = <r2> = 4Dtα, (Equation 4)
where α is the scaling exponent, α = 1 for normal diffusion and α < 1 for anomalous
diffusion.
Confined diffusion: MSD = <r2> = [1 – A1exp(-4A2Dt/<rc2>)], (Equation 5)
where 〈rc2 〉 is an estimation of the confinement size, and A1, A2 are two constants
determined by the confinement geometry. In all equations, D is the diffusion coefficient
(µm2/s), t is the time lag (s), and v is the velocity (µm/s) of the directed motion.
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Based on these Equations, motion-characteristic parameters such as D, v or α can
be determined from the variations of MSD with time lag t, and that is exactly what we get
from tracking particles. The x, y-coordinates generated by particle tracking are used to
calculate MSD. In our experimental setup, each acquisition was 1400 frames with 0.2 s
exposure time and no delay. For MSD calculation, a window segment (or sub-trajectory)
length of 100 frames or 20 s is chosen and shifted along the whole trajectory track with
0.2 s (1 frame) step size so that each trajectory has a total of 1300 sub-trajectories. One
set of time-lag-dependent MSD values is calculated from each sub-trajectory. Plotting
these sub-trajectories versus the time lag results in an MSD curve from which the
characteristic diffusion coefficient D value can be obtained. For the experiment I have
observed, with about 30 to 60 tracked particles, the total number of MSD curves, or
(sub)trajectories, per population can be thousands to tens thousand, supposed to be
efficient to minimize the uncertainty.
Fig. 3.5 shows the average MSD curves of different populations (MOONs in
macrophage cells without toxin addition, MOONs in cells with toxin addition, and
simulated MOONs with random motions). These characteristic curves are the average of
all sub-trajectories of the same population. The curve generated from simulated Brownian
motion in Fig. 3.5a is linear, as expected for the normal diffusive motion. The curve of
motion in cells without toxin treatment is slightly bent from linear, indicating a small
portion of directed transport (Fig. 3.5b). On the other hand, Fig 3.5c shows confined
diffusion, where MSD reaches saturation immediately, implying a very limited motion
and can be explained by the ATP-based motion inhibitors azide and 2-deoxy-D-glucose.
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Fig. 3.5. MSD curves of simulated Brownian motion (a), motion in cells with no toxin addition
(b), and motion in cells with toxin (NaN3 + 2-deoxy-D-glucose) addition (c).

The next step after MSD calculation is fitting. The fitting function basically finds
all the coefficients to present the relationship between MSD and time lag t. To compare
to related studies (125, 127), both Equation 3 and 4 were used for fitting to find the
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diffusion coefficient D, velocity v, and exponent α. Table 3.1 shows these values in cells
not treated with toxin. Compared to a similar experiment on HeLa cells of Holzbaur and
colleagues (127), which has α = 0.32 ± 0.09 and D = 0.006 ± 0.001, our studied
population is more diffusive with significantly higher values of both α (0.71 ± 0.43) and
D (0.022 ± 0.027). It is worth noting that the D values of my data obtained from both
fittings (Dα from Equation 3 and Dv from Equation 4) are the same.
Table 3.1. Motion characterization: D, v and α.

α
Cells with no
toxin added

Average

SD

0.71

0.43

Dα (µm2/s)
Average SD
0.022

0.027

v (µm/s)
Average SD
0.025

0.048

Dv (µm2/s)
Average SD
0.022

0.027

The obtained α values were then used to classify the types of motions. Fig. 3.6
shows histograms of α resulting from fitting MSD data of 36 particles in each of the three
populations: in cells with toxin addition, in cells not adding toxin, and simulated random
motions. While simulated particles resulted in Gaussian distribution of diffusive behavior
and toxin addition caused a confined motion the in cells without toxin histogram showed
a multimodal distribution (multiple peaks), suggesting there were different types of
motion co-occurring in the population. The thresholds to separate the three types,
confined, diffusive and directed motions were chosen based on the normal distribution of
the simulated motions as α1 = ā – 3 σ = 0.61 and α2 = ā + 3 σ = 1.35, where ā is the
average of α and σ is its standard deviation. Using these thresholds, the coefficients
generated from the fitting and also the MSD values can be separated into groups.
Counting the total sub-trajectories of each group gives the percentage (over all sub-
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trajectories) of each motion type. The variation of this percentage value among 6 groups
of 6 particles is shown in Table 3.2.

Fig. 3.6. Motion classification based on α. The α histograms of three populations of 36 particles
(total of 46800 sub-trajectories).

In the toxin addition population, the particles don’t show any normal diffusion
(0%) or directed motion (0%) (Table 3.2). Compared to the corresponding results of
Holzbaur and colleagues study on HeLa cells (127), our cellular control population
showed to be more dynamic with higher percentages of diffusive (48% versus 39%) and
directed (7% versus 2%) behaviors, and a lower percentage of confined motions (45%
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versus 59%) (Table 3.2). In conclusion, the quantitative analysis based on MSD can be a
reliable tool to evaluate cytotoxicity.
Table 3.2. Motion characterization: percentage of confined, diffusive and directed motion.

Cells with no toxin addition
Cells with toxin addition
Simulated particles

Confined
diffusion
45 ± 19%
100% ± 0%
0% ± 0%

Normal
diffusion
48 ± 16%
0% ± 0%
100% ± 0%

Directed
motion
7 ± 4%
0% ± 0%
0% ± 0%

Conclusions and Future Work

Intracellular transport mechanisms can be elucidated by using rotational and
translational tracking of single anisotropic-optical tracers. Moreover, observation over an
ensemble of MOON tracers provides the global characteristics of that population and can
be used to distinguish different populations. The potential of applying this rotation and
translation tracking system to study cytotoxicity was confirmed using intracellulartransport-inhibitory cytoskeletal drugs.
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CHAPTER FOUR
SUMMARY AND FUTURE WORK
In summary, this research explored the potential of anisotropic optical tracers
together with rotational and translational SPT technique in studying biophysical
processes. Anisotropic optical tracers have asymmetric optical properties so that their
intensity is orientation-dependent. Fabrication of these tracers from spherical fluorescent
probes is quite simple. Basically, a thin metal layer is vapor deposited on one hemisphere
of these probes. Tracking the rotation and translation of these tracers using fluorescent
microscopy in a gel can report the appearance of an enzyme or a chemical that causes
viscosity changes in the gel. The same system also can be used to study dynamic
processes such as intracellular transport in macrophages in which tracers are
phagocytosed into the phagosome and transported by cellular protein motors. The
intracellular transport behavior can be employed to evaluate cytotoxicity as well. This is
the first time rotational and translational SPT is used to study cytotoxicity.
For cell work, the most important factor to obtain reproducible results is the
consistency of experimental conditions between experimental batches of cells such as the
cell confluence when imaging. Improvements can also be made in: reducing the exposure
time and the observation time to minimize the effect of illuminating light on cell health;
increasing the temporal resolution for higher tracking accuracy; and optimizing the
tracking algorithm for a faster, more efficient and more accurate tracking. With these
improvements, we expect to be able to build a calibration curve from varied
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concentrations of particulate matters. The curve will establish our first step toward the
quantitative evaluation of particulate matter cytotoxicity.
Not only for intracellular processes, our rotational and translational SPT system
can also have its use in investigating the interactions or processes on cell membrane as
presented in Appendix B. Here a ~ 4 µm MagMOON, made from a Fe3O4 core and
coated with Au on one hemisphere, was tracked while being modulated by an external
magnetic field. Its binding to the cell membrane was detected by the magnetic
modulation amplitude depletion. Due to its large size (4 µm ) and strong magnetism, this
MagMOON caused mechanical stress on the bound cell since it still rotated, although
with smaller amplitude than that before binding, in response to the external magnetic
field. Eventually, the cell ruptured and the MagMOON was released and showed strong
modulation again. This work suggests the potential of using our method to study
processes on cell membranes.
Another future direction is utilizing different tracer types, including size and
shape variations. Our group continues to try applying smaller optical magnetic tracers
(200 nm or less) so that they can be easily manipulated by an external magnetic field after
being phagocytosed. Beside spherical probes, Zhang from our group also successfully
synthesized (several nanometer in diameter and a couple of hundred nanometer long)
silver nanoribons (81, 137) that may be good candidates for studying biophysical
processes using rotational SPT technique based on their anisotropic optical properties.
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APPENDICES
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Appendix A - Poster presented at PITTCON 2011 in Atlanta, GA
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Appendix B - Poster presented at 2012 Magnetic Carrier Meeting in Minneapolis, MN
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Appendix C
Matlab Script for Particle Tracking
------------------------PARTICLE TRACKING----------------------function[MxT,MyT,meanItotal,maxItotal,meanI0,meanIBG,ameanBG,CIntT]=ptr
ack_V35(n0ofparticles, framerate,frns,sw1,sw2,XY, thresh)
%This program tracks blinking praticles based on their centroids.
%Find the centroid position within a specific region in the first
%frame, then continue finding it within a limited area around the first
%point.
Coordinations x,y of the particles need to be put in XY matrix ahead.
%the numberofparticles needs to be n+1 since you have the background at
the end.
%n0ofparticles: number of particles to track that was listed in XY
matrix (including the background point)
%framerate: frame/sec; frns: 1:n;
%sw1: stepwise to calculate mean and max; sw2: stepwise of tracking
area;
% XY: matrix of coordinations of the ROI, chosen at first frame.
% Thresh: the threshold chosen that is higher than background but
better be lower than particle intensity when it is dark.
% OPEN FILE
[fn pn]=uigetfile('*.tif');
cd(pn);
% MAIN BODY
% Display running progress (number of particles)
for j=1:n0ofparticles-1,
display particle; display(j)
[x]=XY(j,1);
[y]=XY(j,2);
% Display running progress (every 100 frames)
for i=1:size(frns,2),
if rem(i,100)==0, display(i); end;
I(:,:,:)=imread(fn,frns(i)); %read image i
if i==1,
%figure; imshow(I*256);
J2=(I(y-sw2:y+sw2,x-sw2:x+sw2));
%figure; imshow(J2*256);
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[Cx(i), Cy(i), CInt(i)]=centroid(J2,thresh); %calculate
centroid
Cx(i)=Cx(i)+(x-sw2)-1;
Cy(i)=Cy(i)+(y-sw2)-1;
else %after the first frame
J2=(I(round(Cy(i-1))-sw2:round(Cy(i-1))+sw2, round(Cx(i1))-sw2:round(Cx(i-1))+sw2));
[Cx(i), Cy(i), CInt(i)]=centroid(J2,thresh); %calculate
centroid
Cx(i)=Cx(i)+round(Cx(i-1))-sw2-1;
Cy(i)=Cy(i)+round(Cy(i-1))-sw2-1;
end; %end find centroid if frame i=1 or not
% CALCULATION OF MEAN AND MAX INTENSITY
meanI(i)=mean(mean(I(round(Cy(i))sw1:round(Cy(i))+sw1,round(Cx(i))-sw1:round(Cx(i))+sw1)));
maxI(i)=max(max(I(round(Cy(i))sw1:round(Cy(i))+sw1,round(Cx(i))-sw1:round(Cx(i))+sw1)));
end; %for each frame
meanItotal(:,j)=meanI;
maxItotal(:,j)=maxI;
MxT(:,j)=Cx;
MyT(:,j)=Cy;
CIntT(:,j)=CInt;
end;
% TRACKING BACKGROUND REFERNCE POINT
for p=1:size(frns,2),
I(:,:,:)=imread(fn,frns(p));
J3=I(XY(end,2)-10:XY(end,2)+10,XY(end,1)-10:XY(end,1)+10);
[Cx0(p), Cy0(p), CInt0(p)]=centroid(J3,100); %calculate centroid
meanI0(p)=mean(mean(I(round(Cy0(p))sw1:round(Cy0(p))+sw1,round(Cx0(p))-sw1:round(Cx0(p))+sw1)));
maxI0(p)=max(max(I(round(Cy0(p))sw1:round(Cy0(p))+sw1,round(Cx0(p))-sw1:round(Cx0(p))+sw1)));
end;
% AUTOCORRELATION CALCULATION
s=size(frns,2); %s is number of frames in movie.
for k=1:n0ofparticles-1,
%for each particle k
meanIBG(:,k)=meanItotal(:,k)-meanI0(:,1);
ameanBG(:,k)=auto(meanIBG(:,k),s-2);
end;
amax(:,j)=auto(maxItotal(:,j),size(frns,2)-2);
amean=auto(meanItotal,i+(k-1)*period);

---------------------------------END-----------------------------------
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Appendix D
Matlab Script for MSD Calculation
------------------------MSD CALCULATION----------------------function[msdr, msdrA]=MSD_no_var(MxT,MyT,n0ofparticles,segL,c,frns,s)
%This function calculates Mean Squared Displacement for all
trajectories of
%all particles within a population.
% Each acquisition is 1400 frames with 0.2 s exposure time and no
delay.
% For MSD calculation a window segment (or sub-trajectory) length
(segL) of 100 frames or 20 s is chosen and shifted along the whole
trajectory track with 0.2 s (1 frame) step size. So each trajectory has
total of 1300 sub-trajectories.
% One set of time lag-dependent MSD values is calculated from each subtrajectory.
% MSD was taken over all 1400 frames, not cutting into smaller tracks
(frns = s = 1400, scanning step c = 1 unit)
% msdr: mean squared displacement in r (both x and y movement)
% msdrA: mean of all msdr
% s is number of frames in movie.
%segL: length of each segment; here all segments have equal length;
scan a window of "segL" length through the whole movie length
n=n0ofparticles;
msdr=zeros(segL-1,n*floor((frns-s)/s)*floor((s-segL)/c));%create zero
matrix
for p=1:n0ofparticles,
display(p);
for w=1:floor(frns/s),%w = number of sections of s frames from
original Mx, My
qa=(w-1)*s;
for ns=1:floor((s-segL)/c), %ns = n0ofsegments;
q=(ns-1)*c; % the position in the whole movie
for m=1:segL-1,%calculation for each segment
%displacement vector
deltaX=MxT(m+q+qa:segL+q+qa,p)-MxT(1+q+qa:segLm+1+q+qa,p);
deltaY=MyT(m+q+qa:segL+q+qa,p)-MyT(1+q+qa:segLm+1+q+qa,p);
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%squared displacement vector
sdx=deltaX.^2;
sdy=deltaY.^2;
sdr=sdx+sdy;
%mean squared displacement
msdr(m,ns,p)=sum(sdr)/length(sdr);
end;
end;
end;
end;
msdrA=msdr(1:segL-1,:);

---------------------------------END-----------------------------------
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Appendix E
Matlab Script for Motion Classification
------------------------MOTION CLASSIFICATION----------------------%This is a sample script for MSD analysis of inputs Mx140 and My140.
Mx140,My140 size is (1400,58) <1400 frames, 58 particles>
%Outputs include percentages of directed motion, normal diffusion and
%confined diffusion over all (sub)trajectories; mean values in all and
in each group of motion of diffusion coefficients D, exponent alpha,
and velocity v.
%I. MSD CALCULATION
%1. Load Mx140, My140
%2. Change unit from pixel to um:
Mx140um=Mx140*0.43;My140um=My140*0.43;
%3. Calculate MSD by the script MSD_no-var: for nd140 (in cell no
toxin), 58 particles, segL = 100; take MSD over all 1400 frames, not
cutting into smaller tracks (frns = s = 1400)
[msdr140um]=MSD_no_var(Mx140um,My140um,58,100,1,1400,1400);
%Result of MSD calculation above is MSD as a function of time lag from
1 frame to 99 frames; for all particles and all trajectoris of 100
frames in length.
%---------------------------------------------------------------------%II. FITTING
t=[0.2:0.2:1]';
a=msdr140um(2:6,:);
total=size(a,2);
xdata=t;
%1. Fitting the normal and abnormal (alpha <1) motion (Equation 4)
% y = x(1)*tx(2) , whereas x(1) = 4D and x(2)=alpha; y=MSD, t=time lag
% Replace t with xdata, y with F,
%F=@(x,xdata)x(1)*xdata.^x(2) ;
%So just need to assign xdata as time lag vector t; and y as MSD
for i=1:total, x(1)=0.0034;x(2)=1; y=a(:,i);
F=@(x,xdata)x(1)*xdata.^x(2) ;
[x,resnorm,~,exitflag,output] = lsqcurvefit(F,x,t,y); xtest7(:,i)=x;
end;
%2. Fitting the directed motion (velocity). Equation 3
%y = x(1)*t + x(2)^2 *t^2, whereas x(1) = 4D and x(2)=~v^2; y=MSD,
t=time lag
% Replace t with xdata, y with F,
%F=@(x,xdata)x(1)*xdata+x(2)*xdata.^2;
%So just need to assign xdata as time lag vector t; and y as MSD
for i=1:total, x(1)=0.0034;x(2)=1; y=a(:,i);
F=@(x,xdata)x(1)*xdata+x(2).^2*xdata.^2;
[x,resnorm,~,exitflag,output] = lsqcurvefit(F,x,t,y);
xtest6(:,i)=x;
end;
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%---------------------------------------------------------------------%checking hist of alpha to choose thresholds c1 and c2
figure; hist(xtest6(2,:),50);
c1=0.61; c2=1.35;
%---------------------------------------------------------------------%III. GROUPING MSD AND D, ALPHA, (VELOCITY)
%Grouping MSD after motion classification and % calculation Normal
fitting Alpha (the same for both models)
%Make sure only needed values are present, to avoid same name conflict;
input NEED: msdr140um; xtest7; c1;c2;
a2=msdr140um(1:99,:);
k=0;k1=0;k2=0;k3=0;
for i=1:size(a2,2),
if xtest7(2,i)> c2, %classify sliding
xslide(:,k1+1)=xtest7(:,i);
MSDslide(:,k1+1)=a2(:,i); k1=k1+1;
else
if xtest7(2,i)<c1, %classify immotile
xim(:,k3+1)=xtest7(:,i);
MSDim(:,k3+1)=a2(:,i); k3=k3+1;
else %remaining is diffusive
xdif(:,k2+1)=xtest7(:,i);
MSDdif(:,k2+1)=a2(:,i); k2=k2+1;
end;end;end;
%--------------%REPEAT FOR THE DIRECTED MOTION MODEL WITH xtest6
%--------------%IV. CALCULATION
%Generate percentage, mean and std of Alpha and Diffusion coefficient
pcim=size(xim)/(size(xslide)+size(xim)+size(xdif))
pcslide=size(xslide)/(size(xslide)+size(xim)+size(xdif))
pcdif=size(xdif)/(size(xslide)+size(xim)+size(xdif))
meanD140=mean(xtest6(1,:))
stdD140=std(xtest6(1,:))
meanD140im=mean(xim(1,:))
stdD140im=std(xim(1,:))
meanD140dif=mean(xdif(1,:))
stdD140dif=std(xdif(1,:))
meanD140slide=mean(xslide(1,:))
stdD140slide=std(xslide(1,:))
meanA140=mean(xtest6(2,:))
stdA140=std(xtest6(2,:))
meanA140im=mean(xim(2,:))
stdA140im=std(xim(2,:))
meanA140dif=mean(xdif(2,:))
stdA140dif=std(xdif(2,:))
meanA140slide=mean(xslide(2,:))
stdA140slide=std(xslide(2,:))

---------------------------------END-----------------------------------
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Appendix F
License Agreement
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